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The World Health Organization sees the increase in chronic diseases as “one of the greatest 
challenges that will face health systems globally in the twenty-first century”. Chronic disease 
affects around 50% of the US adult population, with 25% having multiple chronic conditions. 
Patient engagement and participation in their own care, are essential for the effective control and 
management of their conditions. The achievement of patient engagement is multifaceted. It can 
be affected by access to care, belief and knowledge, provider relationships, provider actions, co-
morbidities, and personal and social circumstances. A better understanding of key factors that are 
associated with a patient achieving engagement would enable interventions to be taken that 
would increase engagement and ultimately improve care quality and outcomes. 
 
Care management has been advocated as a model of care for individuals with chronic conditions 
to improve health outcomes and quality of care, through improving care coordination, patient 
support and self-management. Care management has been found to be associated with better 
quality and satisfaction in care, but results with respect to cost savings differ, and changes in 
utilization are mixed. An important aspect in care management participation is understanding 
how people engage with their care, and the underlying beliefs that would lead to decisions to 
participate in care programs. For care management to be effective, not only must patients 
participate but also engage with their care and the health professionals supporting them. What 
influences a patient’s engagement and the resulting outcomes are important to understand in 





Goals and Aims 
The overarching goals of this project were to develop measures of patient care management 
program participation for persons with chronic disease, to gain understanding of the underlying 
factors and consequences of this participation in order to help improve the care management 
process. 
 
The specific aims of the study are: 
1) To develop an approach for defining and measuring the achievement of patient participation in 
the care management context; 
2) To apply these measurement constructs to determine which individual and organizational 
factors are associated with patients’ active engagement in their own care; 
3) To develop a model to predict participation at various stages in the disease management cycle 
and to estimate the independent effects of participation on care process and utilization; and 
4) To create and recommend metrics for the measurement of care management participation 
across the study populations to enhance understanding of patient groups and sub-populations. 
 
The study population included adult patients during the period September 1, 2009 to December 
31, 2012 identified for care management in three Johns Hopkins Healthcare health plans. The 
study focused on care provided under contract to the managed care plans including primary care, 
outpatient and inpatient hospital care and care management intervention programs. The study 
data consisted of administrative health plan data including claims, enrollment files, care 
management records and patient self-reported data where available. The design was 
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retrospective, focusing on a population of patients screened for care management across a 3-year 
period. There were two main dependent variables, enrollment/participation in care management 
programs and future health expenditure. 
 
A measure of participation, whether an individual enrolled or did not enroll in care management, 
was derived from claims and care management data during the initial stages of the study. A 
predictive model was produced from the routine administrative data, utilizing the patient 
variables associated with participation, to predict future cost and this was validated across all 
three health plans. A further predictive model was produced with the addition of patient reported 
variables from the Personal Wellness profile, and created a Care Management Participation 
Likelihood (CMPL) score based on each of the available consumer reported and administrative 
variables. Four sub-population “care complexity” groups were created using a modified factor 
analysis and clustering method. The future (year 2) health expenditures were compared for the 
care management enrollees against the non-enrollees using two paired matching algorithms. 
 
Findings 
Cost reductions were shown overall for the care management enrolled populations across the 
three plans, with the analysis across the complexity sub-groups showing that the cost reduction 
was achieved across three of the four sub-groups, with the exception of increased costs for the 
most complex group. Patients with higher multimorbidity, and older patients, holding other 
effects the same, were associated with a lower propensity to enroll in care management 
programs. Higher enrollment in the care management programs (holding other effects the same) 
was shown therefore in younger and less multimorbid patients. Higher propensity to enroll was 
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also found in black patients compared to white patients for the Medicare plan. For all plans, 
members who had been referred to care management also showed increased enrolment. Multi-
level (random effects) models were utilized to check that these effects remained when 
accounting for the higher level regional and case manager effects. 
 
Using two Propensity Scoring methods all three plans showed cost reductions for care 
management enrollees compared to non-enrollees. The Employee plan showed cost reductions 
for care management enrollees from $4186.91 to $4486.86 (17.1% - 18.3%), the Medicaid plan 
showed reduced costs of between $1372.66 and $4074.07 (4.6% - 13.3%), and the Family Health 
plan showed cost reductions for those enrolled in care management from $2458.51 to $2604.29 
(7.3% -  7.7%). The plan populations were further broken down into four complexity sub-groups 
derived from the factor and clustering analyses, with the lower costs for care management 
enrolled patients compared to the non-enrolled holding for the three least complex groups, but 
higher costs for enrolled patients in the fourth most complex group. 
 
Summation 
The study, while not seeking to evaluate the current care management programs, provides a 
measure of participation, individual factors underlying participation, predictive models, and 
groupings that could be utilized in future program evaluations. The study is of a managed care 
plan serving multiple populations in Maryland, and while not fully generalizable to all settings, 
could be expected to inform other managed care organizations in the US and worldwide in other 




My thanks go to my supervisor Professor Jonathan Weiner for his support, advice, patience and 
encouragement in completing this thesis, to my thesis advisory committee for their timely input, 
consideration and expertise, Dr Bruce Leff, Dr Laura Morlock, Dr Elizabeth A. Stuart, and 
particularly to Dr Martha L. Sylvia for helping me formulate the original research ideas, 
supporting the acquisition of the data, and for her patience and insight. I would also like to 
acknowledge additional support from Dr Felicia Hill-Briggs, Dr Lilly Engineer and Dr Jill 
Marsteller. 
 
I would like to thank Dr David Bodycombe and Dr Klaus Lemke in the School of Public Health 
for their help discussing methods and SAS scripts. My gratitude to colleagues in Johns Hopkins 
Healthcare for supporting my original data request, reviewing my findings and providing input: 
Dr Linda Dunbar, Dr Peter Fagan, Dr Sarah Kachur, Melissa Sherry, Martin Raffel, Cassandra 
Peterson and Hemalatha George. I would also like to acknowledge the assistance given to me by 
other faculty at Johns Hopkins including Dr Cynthia Boyd, Dr James Tonascia, Dr Debra Roter, 
Dr J. Hunter Young, Dr Vanya Jones and Johns Hopkins alumni Dr Efrat Shadmi, Dr Patricio 
Muniz, Dr Eva Chang, Dr Alexo Esperato and Dr Paulo Boto. 
 
I would also like to acknowledge the support and understanding of colleagues in the Johns 
Hopkins ACG team, Dr Karen Kinder, Chad Abrams, Normalie Barton, Alan Thompson, Dr 
James Barrett, Dr Nihat Yurt and Harriet Martyn,  
 
vii 
A special thanks to my wife Deb, for cajoling, proof reading and helping me complete another 
round of studies and research; to my mother and father, Hazel and Keith Sutch and my mother-
in-law Dorothy Huthart for encouragement and support. 
 
And finally, in memory of Dr Barbara Starfield, Dr Frederick L. Brancati, and Christopher 
Aisbett for their original encouragement, amazing insight and all too brief advice.  
 
viii 
TABLE OF CONTENTS 
ABSTRACT .................................................................................................................................... ii 
ACKNOWLEDGEMENTS ........................................................................................................... vi 
TABLE OF CONTENTS ............................................................................................................. viii 
LIST OF TABLES ......................................................................................................................... xi 
LIST OF FIGURES ..................................................................................................................... xiv 
1 INTRODUCTION ............................................................................................................ 1 
1.1 Project Introduction ................................................................................................ 1 
1.2 Problem Statement .................................................................................................. 1 
1.3 Background ............................................................................................................. 3 
2 PUBLIC HEALTH SIGNIFICANCE .............................................................................. 6 
3 LITERATURE REVIEW ................................................................................................. 7 
3.1 Overview of Care Management, Engagement and Participation ............................ 8 
3.1.1 Care Management ....................................................................................... 8 
3.1.2 Engagement: self-management and efficacy............................................. 12 
3.1.3 Patient Engagement: Compliance and Participation ................................. 14 
3.1.4 Activation and empowerment ................................................................... 15 
3.1.5 Summary of Care Management, Engagement and Participation .............. 16 
3.2 Conceptual Framework ......................................................................................... 17 
4 METHODS AND RESEARCH DESIGN ..................................................................... 21 
4.1 Study Aims, Objectives, Questions and Hypotheses ............................................ 21 
Aim 1 - Defining and Measuring Participation ................................................................. 21 
Aim 2 - Factors associated with Participation .................................................................. 22 
 
ix 
Aim 3 – Predicting Participation....................................................................................... 22 
Aim 4 - Initial Implementation and Assessment ............................................................... 23 
4.2 Study population ................................................................................................... 23 
4.3 Study Design ......................................................................................................... 27 
4.4 Variables and measures......................................................................................... 27 
4.5 Methods of data collection .................................................................................... 29 
4.6 Analytic approach/Analysis Plan .......................................................................... 32 
4.7 Analytic Objectives by Aim.................................................................................. 33 
Aim 1 - Defining and Measuring Participation ................................................................. 33 
Aim 2 - Factors associated with Participation .................................................................. 36 
Aim 3 – Predicting Participation....................................................................................... 38 
Aim 4 - Initial Implementation and Assessment ............................................................... 42 
5 RESULTS....................................................................................................................... 44 
5.1 Description of Study Population ........................................................................... 44 
5.1.1 Study population summary........................................................................ 46 
5.1.2 Medicaid Plan population: Priority Partners ............................................. 49 
5.1.3 Effects of Region and Care Manager ........................................................ 52 
5.1.4 Employee Health Plan ............................................................................... 55 
5.1.5 US Family Health Plan .............................................................................. 58 
5.1.6 Summary of initial analyses ...................................................................... 60 
5.2 Patient Participation Risk Models ......................................................................... 62 
5.2.1 Models for predicting participation in case management programs ......... 62 
5.2.2 Split half validation ................................................................................... 62 
 
x 
5.2.3 Medicaid Plan Model, Validated on Employee and US Family Health 
plans 70 
5.3 Factor Analysis approaches using additional patient recorded data ..................... 71 
5.3.1 Factor Analysis Updated Model using Personal Wellness Profile Data ... 71 
5.3.2 Personal Wellness Profile Factor Analysis: Adding patient engagement to 
predict CM enrollment .......................................................................................... 72 
5.3.3 Principal Component Cluster Analysis ..................................................... 80 
5.4 Cost and Utilization Outcomes, Year 2 ................................................................ 82 
5.4.1 Cost and Utilization Outcomes, Year 2: Initial results.............................. 82 
5.4.2 Cost and Utilization Outcomes, year 2: Propensity Score Matching ........ 86 
6 DISCUSSION AND CONCLUSIONS .......................................................................... 94 
6.1 Overview ............................................................................................................... 94 
6.2 Summary and Interpretation of Findings .............................................................. 95 
6.2.1 Measuring patient participation ................................................................. 95 
6.2.2 Factors Associated with Care Management participation ......................... 95 
6.2.3 Predicting patient participation ................................................................. 99 
6.2.4 Cost and Utilization outcomes ................................................................ 100 
6.2.5 Sub population analysis ........................................................................... 102 
6.3 Discussion ........................................................................................................... 104 
6.3.1 Available Data Limitations and the Future ............................................. 104 
6.3.2 Patient Factors in Engagement in Care Management ............................. 105 
6.3.3 Implications for Care Management Plans ............................................... 106 
6.4 Study Strengths and Limitations ......................................................................... 108 
 
xi 
6.5 Study Implications .............................................................................................. 113 
6.6 Areas for Future Research .................................................................................. 114 
7 REFERENCES ............................................................................................................. 117 
8 APPENDICES .............................................................................................................. 132 
8.1 Variable list ......................................................................................................... 132 
8.2 Personal Wellness Profile ................................................................................... 138 
8.3 Additional Results ............................................................................................... 139 
8.3.1 Missing Data ........................................................................................... 139 
8.3.2 Logistic Regression – Medicaid plan, Second outcomes ........................ 141 
8.3.3 Logistic Regressions – Random Effects Models..................................... 145 
8.3.4 Year 2 Outcomes ..................................................................................... 149 
CURRICULUM VITAE ............................................................................................................. 155 
 
LIST OF TABLES 
Table 5-1: Demographic Characteristics: Three Health Plans, Mean (sd) ................................... 47 
Table 5-2 Impact of factors on member’s joining (yes/no) CM program: Medicaid population . 50 
Table 5-3 Tests of Covariance Parameters Based on the Residual Pseudo-Likelihood, on Three 
Nested Models, Medicaid plan data .............................................................................................. 52 
Table 5-4 Impact of factors on member’s joining (yes/no) CM program: Selective List of odds 
ratios from Three Nested Models for Medicaid Plan .................................................................... 54 




Table 5-6 Impact of factors on member’s joining (yes/no) CM program: US Family Health Plan
....................................................................................................................................................... 59 
Table 5-7: Predictive Models performance, Split half validation: Random 50% training data, 
50% validation data set ................................................................................................................. 64 
Table 5-8 Validation of predictive model: Performance for selected cut points .......................... 65 
Table 5-9 Model Estimates, Odds ratio, Score ............................................................................. 69 
Table 5-10 Medicaid Plan model, Validated on Employee and US Family Health plans ............ 70 
Table 5-11: Employee Health Plan Descriptive Statistics, PWP Survey...................................... 73 
Table 5-12: Factor Analysis of selected variables: Rotated Factor Pattern .................................. 74 
Table 5-13: CM Participation Likelihood (CMPL) Score: Based on PWP engagement response 
and other variables ........................................................................................................................ 76 
Table 5-14: Results of Cluster Analysis ....................................................................................... 80 
Table 5-15 Employee Health Plan (EHP): Year 2 Outcome Measures, Care Management 
Enrollment (unadjusted)................................................................................................................ 83 
Table 5-16 Medicaid Health Plan: Year 2 Outcome Measures, Care Management Enrollment 
(unadjusted)................................................................................................................................... 83 
Table 5-17 Family Health Plan: Year 2 Outcome Measures, Care Management Enrollment 
(unadjusted)................................................................................................................................... 84 
Table 5-18 Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by Count of 
Chronic Conditions and Major ADGs .......................................................................................... 85 
Table 5-19 Mean Prevalence (probability of CM Enrollment) for two Propensity Score matching 
(PSM) methods ............................................................................................................................. 87 
 
xiii 
Table 5-20 Employee Health Plan: Propensity Score matching, Year 2 Outcome Measures, Care 
Management Enrollment ............................................................................................................... 89 
Table 5-21 Propensity Score matching, Year 2 Total Cost, Care Management Enrollment by Plan 
Sub-Group ..................................................................................................................................... 93 
Table 6-1 Patient factors with reduced likelihood of member’s acceptance to join CM program: 
Three Health Plans ........................................................................................................................ 96 
Table 6-2 Patient factors with increased likelihood of member’s acceptance to join CM program: 
Three Health Plans ........................................................................................................................ 97 
Table 8-1: Demographic Characteristics: Medicaid plan, CM Moderate Risk ‘Level 2’ Screened, 
Mean (sd) .................................................................................................................................... 140 
Table 8-2 Impact of factors on predicting member’s acceptance to join CM program: Medicaid 
population, Second Outcome where First accepted CM ............................................................. 141 
Table 8-3 Impact of factors on predicting member’s acceptance to join CM program: Medicaid 
population, Second Outcome where First declined CM ............................................................. 143 
Table 8-4 Impact of factors on predicting members’ acceptance to join CM program: Care 
Manager Nested Model, Medicaid Plan ...................................................................................... 146 
Table 8-5 Impact of factors on predicting members’ acceptance to join CM program: Region 
Nested Model, Medicaid Plan ..................................................................................................... 147 
Table 8-6 Impact of factors on predicting members’ acceptance to join CM program: Region 
(Care Manager) Nested Model, Medicaid Plan .......................................................................... 148 
Table 8-7 Year 2 Total Cost by Health Plan, Care Management Enrolled v Not Enrolled ........ 149 
Table 8-8 Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled ................... 150 
 
xiv 
Table 8-9 Table Year 2 Mean Cost, Inpatient Rate, ER Rate by Health Plan, Care Management 
Enrolled v Not Enrolled .............................................................................................................. 150 
Table 8-10: Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by Care 
Management Level and Screened by Algorithm (or Referral) ................................................... 151 
Table 8-11 Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by Count of 
Chronic Conditions and Major ADGs ........................................................................................ 154 
 
LIST OF FIGURES 
Figure 3-1: Healthcare Utilization and Conceptual Model* ......................................................... 18 
Figure 3-2: Patient, Provider and Care Management Interactions: A Conceptual Model ............ 19 
Figure 4-1 JHHC Care Management (CM) Screening Algorithm ................................................ 26 
Figure 4-2 Data collection timeline .............................................................................................. 31 
Figure 5-1: Consort Flow Diagram ............................................................................................... 45 
Figure 5-2 Care Management Enrollment Rate by Chronic Condition Count: Medicaid Plan .... 48 
Figure 5-3 Care Management Enrollment Rate by Major ADG: Medicaid Plan ......................... 48 
Figure 5-4 Comparison of ROC Curves: 50% Split-half Validation data set ............................... 66 







1.1 Project Introduction 
The overarching goals of this project were to develop measures of patient care management 
program participation for persons with chronic disease, to gain understanding of the underlying 
factors and consequences of this participation and to help improve the care management process. 
 
Accordingly, the specific aims of the study are: 
1) To develop an approach for defining and measuring the achievement of patient 
participation in the care management context; 
2) To apply these measurement constructs to determine which individual and organizational 
factors are associated with patients’ active engagement in their own care; 
3) To develop a model to predict participation at various stages in the disease management 
cycle and to estimate the independent effects of participation on care process and 
utilization;  
4) To create and recommend metrics for the measurement of care management participation 
across the study populations to enhance understanding of patient groups and sub-
populations. 
 
1.2 Problem Statement 
In 2012 49.8% of US adults had at least one chronic disease, and 25.5% had two or more chronic 
diseases (Ward, Schiller, & Goodman, 2014). A key component of the care of individuals with 
chronic diseases is their engagement in appropriate health care services.  Currently there is no 
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clear definition of “engagement” or of the factors that affect whether patients will participate 
with the healthcare delivery system in the management of their care.  For patients with chronic 
diseases early involvement is an important factor that influences a patient’s ability to control and 
manage their condition (Wagner et al., 2001). For example, the patient must interact with their 
primary care physician to agree on a care plan, and participate in self-management activities, 
tests, examinations and prescribed interventions. Care guidelines include a number of 
recommendations for examinations and tests that are often carried out across multiple providers 
initiated by patients themselves.  
 
The term engagement has been used to describe the interaction between a healthcare 
organization and it’s patients, in communicating and building a relationship. Patient engagement 
is multifaceted and can be affected by the access to care, beliefs, provider relationships, provider 
actions, co-morbidities, personal and social circumstances (Graffigna, Barello, Bonanomi, & 
Lozza, 2015; Longtin et al., 2010; Powell, Doty, Casten, Rovner, & Rising, 2016). Engagement 
of an individual can also be transitory, with engagement increasing following signal events, such 
as a new diagnosis or a hospital admission. Without a meaningful reproducible measure of 
engagement or participation, other factors related to the care management process may not be 
well recognized. A better understanding of key factors and their inter-relation with care 
management participation would likely enable interventions intended to increase engagement 
and ultimately improve care quality and outcomes. 
 
This study examined patient participation in care management programs. Specifically, 
participation was measured in two ways: whether a member enrolled in a care management 
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The World Health Organization sees the increase in chronic diseases as “one of the greatest 
challenges that will face health systems globally in the twenty-first century” (Nolte & McKee, 
2008). In 2012 49.8% of US adults had at least one chronic disease, and 25.5% had two or more 
chronic diseases (Ward et al., 2014). Chronic diseases lead to many complications, and interact 
with other conditions such as mental illness to create exacerbations. Major chronic diseases 
include cardiovascular diseases (heart disease and stroke), cancer, diabetes, arthritis, obesity, and 
chronic respiratory diseases (asthma and chronic obstructive pulmonary disease). Further, 
chronic disease co-occurs; the incidence of adults with two or more chronic conditions has 
increased significantly in the first decade of this century, the estimated number of US adults over 
25 with chronic conditions from 2001-2009 rose from 23.4 million to 30.9 million (Ford, Croft, 
Posner, Goodman, & Giles, 2013). Specific chronic conditions such as diabetes are estimated to 
affect 8.3% of the population (25.8 million people in the US) and can lead to major 
complications including heart disease and stroke.  Diabetes, for instance, is also the leading 
cause of kidney failure, non-traumatic lower limb amputations, and blindness in US adults. 
Chronic conditions also disproportionately affect different populations, such as the African 




A key component of the care of individuals with chronic diseases is their engagement in 
appropriate health care services.  It is important to involve patients early to control and manage 
their conditions. There is no clear definition of “engagement” with respect to healthcare and the 
factors that affect whether a patient will or will not engage with the delivery system are still not 
fully understood. The Baldrige Framework in assessing performance excellence identifies 
customer engagement as a goal of a successful Healthcare organization, and describes customer 
engagement as the willingness of patients to seek health services and advocate for those services 
(The National Institute of Standards and Technology, 2011). Communication, building of 
relationships with patients, active involvement and satisfaction are factors shown to be 
associated with engagement. 
 
Care management has been advocated as a model of care to improve health outcomes and quality 
of care, through improving care coordination, patient support and self-management. Care 
management can be described by a number of terms that have become synonymous: disease 
management; case management; coordinated care; integrated care; multidisciplinary care. 
(Krumholz et al., 2006). Where, for example, disease management had been usually associated 
with the care for a specific condition and disease process, increasingly such programs have 
considered the treatment of comorbid and multimorbid patients. Previous evaluations of care 
management programs have identified the difficulties that patients have in adjusting their 
lifestyle to manage their condition; for example, diet (Ibrahim, Beich, Sidorov, Gabbay, & Yu, 
2002). Care management has been found to be associated with better quality and satisfaction in 
care, but results with respect to cost savings differ, and changes in utilization were mixed (Boult 
et al., 2009; Hong, Siegel, & Ferris, 2014). There is a continuing need to develop programs and 
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interventions for high need populations, and a need to change culturally to ensure effective 
communications between interdisciplinary team members and the “promotion of patient and 
caregiver engagement in the care process” (Blumenthal, Chernof, Fulmer, Lumpkin, & Selberg, 
2016; Hong et al., 2014). 
 
An important aspect in care management participation is understanding how people engage with 
their care, and the underlying beliefs that would lead to decisions to participate in care programs. 
For care management to be effective not only must patients participate but also engage with their 
care and the health professionals supporting them. What influences a patient’s engagement and 
the resulting outcomes are important to understand in order to ensure care management 





2 PUBLIC HEALTH SIGNIFICANCE  
The study will develop methods to help understand and define engagement, and to identify 
patient factors that are associated with the propensity of patients to become actively involved 
with a health care organization in the management of their health problems. The study, while not 
seeking to evaluate the current disease management program, does develop and test a measure 
for participation that could be utilized in future program evaluations. 
 
The study was conducted in a managed care plan serving multiple populations, consisting of an 
employee health plan, Department of Defense family plan, and a Medicaid plan, and would be 
expected to inform other managed care organizations in the US and worldwide.  The output from 
the study could be used to help optimize business operations in order to identify the appropriate 
members for case and disease management services. This would not only apply to those 
individuals most amenable to such programs, but also to identifying factors associated with poor 
engagement; allowing future programs to target interventions that offset such factors. The 
intended study population includes enrollees in a Medicaid health plan, and therefore findings 
and conclusions would be policy relevant with respect to the Maryland State Medicaid Mandated 
Managed Care Plan (DHMH, 2002) of which the Johns Hopkins Healthcare (JHHC) Managed 
care Plan Priority Partners is a part. The factors identified by the study related to participation 
should provide insight in to whether the care management programs are effectively targeting the 





3 LITERATURE REVIEW 
An important aspect in care management participation is understanding how people engage with 
their care, and the underlying beliefs that would lead to decisions to participate in care programs. 
For care management to be effective not only must patients participate but also engage with their 
care and the health professionals supporting them. What influences a patient’s engagement and 
the resulting outcomes are important to understand in order to ensure care management 
interventions are appropriately designed and implemented. This section reviews the literature 
regarding care management participation and patient engagement. 
 
A literature search was undertaken with respect to the term “case management”, “engagement”, 
“patient engagement”, “participation”, and associated Medical Subject Headings (MeSH) term 
“Self-Management”, including and excluding the terms “chronic” and “comorbidity” via online 
searches of PubMed and CINAHL (Cumulative Index to Nursing and Allied Health Literature) 
literature databases. Relevant articles were identified that included descriptions of engagement, 
measures, surveys and frameworks. 
 
Engagement and participation are linked in the literature with multiple concepts, such as self-
management/self-care, compliance, self-efficacy, activation, and to the process of 
communication between patient and providers (Graffigna et al., 2015; Longtin et al., 2010; 
Powell et al., 2016). These in turn link to the supportive care to patients from care givers, 
families and the engagement of the providers in supporting patients in designing suitable care 
plans that are consistent with clinical guidelines. The literature also shows that individual states 




3.1 Overview of Care Management, Engagement and Participation 
3.1.1 Care Management 
Care management can be described by a number of terms that have become synonymous 
(Krumholz et al., 2006). These include: disease management; case management; coordinated 
care; integrated care; multidisciplinary care. Where for example disease management had been 
usually associated with the care for a specific condition and disease process, increasingly such 
programs have considered the treatment of comorbid and multimorbid patients. The types of care 
models can be categorized by the services that they encapsulate, who is leading the care 
coordination and care provision, and the patient population being targeted. Boult and colleagues 
(Boult et al., 2009) undertook a comprehensive review of research showing improvement in 
quality and outcomes, and identified 15 specific models of care that showed improvements in 
outcomes. This meta-analysis applied criteria to ensure the research studies used valid data 
collection methods, analyses, and measures, which significantly reduced the number of articles 
included in the research from the original literature search. Care management was simply 
described by Boult et al as a collaborative approach to care involving a nurse or social worker 
working with the patient and family. Care management was found to be associated with better 
quality and satisfaction in care, but results with respect to cost savings differed, and utilization 
changes were mixed.  
 
A report by The Commonwealth Fund (McCarthy, Ryan, & Klein, 2015) categorized 
coordinated care models according to primary care, hospital to home, at home care, care in 
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nursing homes, and care in hospitals. The care coordination can also be delivered directly to the 
patient via nurses, physicians or other health professionals, to individual patients or groups, or 
indirectly via telephonic or other interactive technology. The report also evidenced the impact of 
these programs, which vary across a number of quality and outcome domains, highlighting the 
lack of evidence showing reduction in costs, and concludes the need to ensure proper 
measurement of programs particularly with a “already fragmented fee-for-service care system”. 
A subsequent recent report from Commonwealth Fund highlighted the continuing need to 
develop programs and interventions for high need populations, referencing the lack of consistent 
results from comprehensive care models, and in particular emphasizing that changes were also 
needed culturally to ensure effective communications between interdisciplinary team members 
and the “promotion of patient and caregiver engagement in the care process” (Blumenthal et al., 
2016; Hong et al., 2014). 
 
Identifying patients for care management can occur through multiple methods: referrals by 
physicians, screening statistical algorithms, or patient surveys. Shadmi and Freund (Shadmi & 
Freund, 2013) advocated multiple combined approaches to avoid bias in selection by the 
individual methods. Weir et al reviewed three different statistical screening algorithms for the 
purposes of case selection in the Vermont Medicaid program: Chronic Illness and Disability 
Payment System (CDPS); Diagnostic Cost Groups (DCG); Adjusted Clinical Groups Predictive 
Model™ (ACG-PM™) (Weir, Aweh, & Clark, 2008). The costs weights (predictions of future 
costs) produced by the three systems were used to nominally select patients, with the results 
compared to the actual second year costs, and found that the ACG system performed best for the 
lowest 90% of the population and the DCG system performed best for the top 1%. They also 
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included a comparison of hospitalization predictions and found the ACG system had advantages 
over the other two systems for the top 10% and 1% at risk populations. In addition to using the 
risk of high cost and future hospitalization, other measures such as emergency department visits 
and long stay hospitalizations risk have been advocated for use in patient identification for care 
management. These other measures were used by Crane and colleagues to screen for at risk of 
hospitalization for frail elderly patients using the elders risk assessment index (Crane et al., 
2010). 
 
With respect to whether patients participate in care management programs when they are offered, 
the study by Kalsekar and colleagues (Kalsekar, Record, Nesnidal, & Hancock, 2010) analyzing 
National Ambulatory Medical Care Survey (NAMCS), showed that of patients with at least one 
chronic condition 21.3% enrolled in disease management programs. The study showed higher 
enrollment for Medicare and Medicaid compared with other health plans (although they 
concluded that this was not statistically significant). An earlier study (Lynch, Chen, Bender, & 
Edington, 2006) had showed a higher rate of initial participation by members of employee health 
plans who had diabetes in disease management programs (42.1%) but a high attrition rate at 6 
months reduced the participation rate to 14.0% and at 12 months to 6.3%. In Australia Hoang 
and Jones (Hoang & Jones, 2006) investigated whether the uptake rate for disease management 
programs could be increased using incentives or different approaches (e.g. phone, mail), but 
concluded these did not lead to significant changes. To be effective in improving health 
outcomes, single interventions such as education have not been found to be effective on their 
own, but were effective when employed as part of a range of interventions at multiple levels 
(Ferlie & Shortell, 2001). A whole systems approach was recommended by Serrano-Gill and 
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Jacob to improve self-management effectiveness, including information for patients, training 
clinicians in patient centered care and patient collaboration, and allowing open access to 
outpatient appointments (Serrano-Gil & Jacob, 2010). With such a multidisciplinary approach 
voluntary Disease Management Programs have been shown to reduce HbA1C levels in diabetic 
patients (Ibrahim et al., 2002). However, Gruber (Gruber, 2010) emphasized the importance of 
patient engagement with their own care, with support from care givers (such as family), if long 
term favorable outcomes are to be achieved, especially when given the expectation of potentially 
poor care coordination, differences in the provision of health care plans and provider incentives 
that are aligned with short term and not long term outcomes. 
 
Care management has been advocated as a model of care to improve health outcomes and quality 
of care, through improving care coordination, patient support and self-management. A range of 
measures have been used in studies to examine the outcomes of care management, and a range of 
factors have been identified the are potential confounders when comparing outcomes between 
different populations. Frank and Epstein (Frank & Epstein, 2014) concluded that younger 
patients under the age of 65 with higher costs due to major multimorbidities such as mental 
health conditions, would benefit from care management programs, particularly in respect to 
coordination of care between mental health services, substance misuse and rehabilitation 
services. Higher costs were linked to higher emergency department visits and inpatient 
hospitalizations. This was also reflected in the analyses of a diabetes disease management 
program in Louisiana also showed lower emergency department visits for patients, and 
furthermore that uninsured patients increase their use of emergency departments, adjusting for 
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gender, age, previous hospitalizations and comorbidity (Chiou, Campbell, Horswell, Myers, & 
Culbertson, 2009). 
 
In evaluating a care management model, quality of care was reviewed with respect to a “Guided 
Care” model by Boyd and colleagues (Boyd et al., 2010) concluding that patient reported ratings 
of care quality after 18 months was higher for those who had received the nurse care 
management intervention, compared to those who were receiving usual care, in particular with 
respect to care coordination and decision support. Berthold and colleagues (Berthold, Bestehorn, 
Jannowitz, Krone, & Gouni-Berthold, 2011) found some of the intermediate outcomes for a 
diabetes management program improved, such as cholesterol, this was not found in a range of 
other measures which did improve over time but this improvement could not be directly 
attributed to the program. This study also highlighted the potential issues of confounding, when 
such disease programs are part of a national implementation (in this case in Germany). 
 
3.1.2 Engagement: self-management and efficacy 
Serrano-Gill and Jacob (Serrano-Gil & Jacob, 2010) discussed the importance of engagement 
and empowerment of patients with chronic a chronic disease (type 2 diabetes) to self-manage. A 
randomized control study in Wisconsin showed that while the clinical care met recommended 
guidelines (Helstad, Wiegmann, Camponeschi, Udlis, & Meredith, 2004), the patients were 
inconsistent in their self-management. Individual factors not related to the clinical treatment such 
as age and education level had been found to be related to the control of diabetes (Nerenz, 
Repasky, Whitehouse, & Kahkonen, 1992), thereby demonstrating the need to understand the 
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efficacy of patients as well as the compliance of health care providers to guidelines and 
complexity of treatments. Engagement in specific self-management behaviors such as glucose 
checks, diet monitoring, exercise and smoking, has been studied with respect to diabetic patients. 
The study investigated the differences by race and ethnicity, an issue relevant to diabetes as a 
condition that disproportionately affects the non-Hispanic black population when compared to 
non-Hispanic whites (77% higher risk of diagnosis).  There were results in different patterns of 
utilizations with black and Hispanic patients in disease management programs showing higher 
levels of hospital visits but lower use of preventative services than white patients (Oster et al., 
2006). The role of the providers as a support to patients was found to be crucial, in ensuring that 
patients engage in the management of their care, and in instilling self-efficacy in undertaking 
self-management activities across different socioeconomic groups (race, ethnicity and health 
literacy) (Greene, Yedidia, & Take Care to Learn Evalutation Collaborative, 2005; Sarkar, 
Fisher, & Schillinger, 2006). 
 
A review of engagement in self-management by patients with disabilities emphasized the 
importance of informed decision making, particularly in selecting providers, and the use of 
information provided by professionals (Lakhani, McDonald, & Zeeman, 2016). Another review 
emphasized the increased importance of social networks to support self-management for chronic 
illness, the importance of being able to navigate networks and the personal and collective 
influences and beliefs that underpin “collective efficacy” (Vassilev, Rogers, Kennedy, & 
Koetsenruijter, 2014). The importance of utilizing information technology by diabetes patients 
has been highlighted by studies that have also assessed the level of engagement in therapeutic 
care plans and a variety of self-management activities (Glasgow, 2010; Grant et al., 2006). Five 
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concepts related to patients engaging in self-management (“self-care”) were identified by 
Blickem and colleagues (Blickem et al., 2011): awareness of alternative self-management 
activities; previous use of information; ability to self-manage; opportunities to self-manage; and 
“congruence and synergy” with the provider. 
 
3.1.3 Patient Engagement: Compliance and Participation 
Lindenmeyer and colleagues (Lindenmeyer, Whitlock, Sturt, & Griffiths, 2010) reported two 
types of behaviors with respect to self-management by diabetic patients. Patients who strictly 
incorporating the recommended interventions into their daily life (such as diet changes) or who 
were applying the recommendations flexibly and where manageable. Wallace (Wallace, 2010) 
identified four categories of patient from providers’ perspectives, related to patients’ level of 
engagement with the management of their diabetes. Patient engagement was described as the 
active participation with the provider to plan the management of their diabetes, and seek to 
follow the provider’s recommendations (“compliance”). The level of engagement labels Wallace 
used were as follows: 1) patients who follow the recommendations of their providers 
(“Autopilot”); 2) those who are active and then become inactive in their management (“Off and 
On”); 3) those who placed a low priority on the management of their diabetes due to other 
priorities such as multi-morbidities (“Back Burner”); 4) and patients who are actively engaged in 
their own management but will be selective in following the recommendations from their 
provider and seek alternative treatments (“Wonder Juice”). Similar characteristics of this latter 
group were also identified in a study by Dettalo and colleagues, who identified the characteristics 
of patients who completed chronic disease self-management programs, and found a cohort of 
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individuals who were dissatisfied with their primary care providers and were seeking alternative 
self-management education (Dattalo et al., 2012). The issue of provider compliance was 
discussed, recognizing the low level of compliance overall, and that the engagement of providers 
themselves can be an issue for patients where there were incomplete examinations and 
consideration of patients’ circumstances. These four categories reflect to an extent the five 
concepts, identified above by Blickem and colleagues, that underlie patients’ engagement in self-
management activities. The American Diabetes Association (ADA) recommends a number of 
activities that require the compliance and participation of the patient and provider, for 
monitoring, examination and control purposes. In addition to the differences noted previously by 
race and ethnicity in the uptake of self-management activities, disparities have also been reported 
in the healthcare provision attributed to issues such as provider adherence to clinical guidelines 
and lack of trust in providers (Greene et al., 2005; Kirk et al., 2005). 
  
3.1.4 Activation and empowerment 
In addition to the self-management and compliance concepts raised above, the interaction 
between patient and provider are important to facilitate engagement. Studies have highlighted the 
importance of a style of communication that is attentive, respectful and committed (Warmington, 
2012), and enables the patient to progress through a “Decision-making continuum”, consisting of 
participation, activation and empowerment (Roter, 2000). These studies show that patient 
engagement can therefore be expressed in respect of the relationship with the provider, whether 
passive or active, leading to a level of activation and participating in the care process and self-
management. Concepts such as race and gender concordance may be important in understanding 
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the relationships and socioeconomic differences already noted. These processes provide concepts 
that are distinct from compliance and indeed advocate styles of engagement where a patient is 
not necessarily compliant with a provider, but an empowered patient would necessarily be 
actively managing and problem solving, with the provider supporting the patient in their 
decisions. 
 
3.1.5 Summary of Care Management, Engagement and Participation 
Previous research shows that engagement and participation are linked with multiple concepts in 
the literature, such as self-management/self-care, compliance, self-efficacy, activation, and to the 
process of communication between patients and providers. These in turn link to the supportive 
care to patients from care givers, families and the engagement of the providers in supporting 
patients in designing suitable care plans that are consistent with clinical guidelines. The literature 
also shows that individual states within the respective concepts are transitory and subject to 
change over time. 
 
Care management is now synonymous with multiple models of integrated and comprehensive 
care, but the results of reviews are mixed. While studies have shown improvement in quality of 
care and patient satisfaction, the evidence for costs savings are not consistent. The understanding 





This study seeks to utilize routine data to derive measures of participation; it will attempt to add 
to the literature by providing an exploration of the patient factors that underlie and effect 
participation in care management across different populations, by providing new models to 
predict participation, and provide a methodology to review the outcomes of patients who 
participate and those who do not, and which sub-populations are of particular interest.  
 
3.2 Conceptual Framework 
To understand the relationship between behaviors associated with engagement and participation, 
and the patient’s costs and utilization of services, two frameworks were identified, the 
PRECEDE-PROCEED framework (Green & Kreuter, 1999) and the behavioral model and 
access to medical care developed by Aday and Anderson (Andersen, 1995). 
 
The PRECEDE-PROCEED framework provides a model to understand the behavioral constructs 
and factors associated with engagement. This model was applied to self-management of diabetes 
by Gielen and colleagues (Gielen, McDonald, Gary, & Bone, 2008) who described the 
predisposing, reinforcing and enabling factors resulting from educational strategies. They 
showed these factors in turn lead to certain behaviors which interact with environmental factors 
(such as the health plan) and give rise to the health problems and clinical markers associated with 
the diagnosis and management of diabetes. A number of the constructs in this framework were 
reflected in the findings of Sousa et al (Sousa, Zauszniewski, Musil, McDonald, & Milligan, 
2004) who concluded that self-care and engagement in self-care were associated with a patient’s 
knowledge, social support, self-care agency, and self-efficacy. 
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The behavioral models developed by Aday and Andersen were originally developed to aid in the 
understanding of health services by families, and subsequently developed as an individual 
behavior model (Andersen, 1995). The framework represents the external environmental 
influences and population characteristics (both individual and provider) that underlie health 
behavior and utilization of health services leading to outcomes (such as health status and 
satisfaction). Figure 3-1, shows the model adapted with the inclusion of the engagement between 
the provider and patient that leads to the health practices undertaken by the patient and to the use 
of health services. This provides for the engagement to be not only a patient issue, sometimes 
described as compliance by providers, but also be applied to the providers in their interaction 




* Adapted from Aday and Andersen (Andersen, 1995) 




Figure 3-2  below, is a conceptual model showing the relationships between the patient, provider, 
care manager and care plan, the beliefs and socioeconomic factors influencing the patient that 
together with the patient’s existing health measures give rise to the processes of care utilized by 
the patient (such as routine examinations and test). The process of care leads in turn to patient 
outcomes such as changes in health services utilization (healthcare expenditure, rates of 
hospitalization or emergency department visits), incidence of complications, or health status. The 
relationship with the provider and the effect of provider behaviors, such as adherence to practice 
guidelines (provider compliance) and collaborative approaches to working with the patient, are 
an important input to the patient’s own engagement, participation and adherence to self-
management. These beliefs, personal health factors and interactions with others lead to the 
patient undertaking processes such as testing, examinations and treatments, which in turn leads 











































This study seeks to measure participation (“Enrollment”) in care management programs, by 
identifying the association of patient factors such as morbidity, race/ethnicity, and 
region/geography. The process of patient participation or non-participation (when controlling for 
patient effects), would be expected to lead to changes in patterns of utilization which in turn lead 
to changes in intermediate outcomes such as health expenditures, rates of hospitalization and 
emergency department visits. The providers of health care services, the care managers, and 
enrollment of patients in a health plan are potential modifying or confounding effects in the 





4 METHODS AND RESEARCH DESIGN 
4.1 Study Aims, Objectives, Questions and Hypotheses 
The overarching goals of this project were to develop measures of patient care management 
program participation for persons with chronic disease, to gain understanding of the underlying 
factors and consequences of this participation and to help improve the care management process. 
The project specific aims and associated study objectives are presented below. 
 
Aim 1 - Defining and Measuring Participation 
Aim 1: To develop an approach for defining and measuring the achievement of patient 
participation in the care management context. 
 
Aim 1 Study Objectives: 
1.1 To derive an operational definition, constructs and a potential measurement 
framework of “patient engagement” in the care management context utilizing the 
scientific and gray area literature and input from key informants and experts. 
 
1.2 To test the feasibility of deriving alternative measures of participation using available 
secondary data and patient reports from available surveys. 
 
1.3 To undertake measurement analytic activities (including factor analysis) to assess the 





Aim 2 - Factors associated with Participation 
Aim 2: To apply these measurement constructs to determine which individual and 
organizational factors are associated with patients’ active participation in their own care; 
 
Aim 2 Study Objectives: 
2.1 To identify individual patient related factors which are independently associated with 
levels of patient participation in care management activities. 
 
2.2 To identify organizational and provider related factors which are independently 
associated with high levels of patient participation in care management activities.  
 
Aim 3 – Predicting Participation 
Aim 3: To develop a model to predict participation at various stages in the disease 
management cycle and to estimate the independent effects of participation on care process and 
utilization; 
 
Aim 3 Study Objectives: 
3.1:  To develop and test a model that will predict which individual patients will likely 
participate at initial and subsequent stages of the care management process. Based on the 




3.2: To assess the independent relationships between patient participation and outcomes 
such as health expenditures, and health services utilization. 
 
Aim 4 - Initial Implementation and Assessment 
Aim 4: To create and begin the dissemination of tools for the measurement of care management 
participation across the study populations to help improve the care management process. 
 
Aim 4 Study Objectives: 
4.1:  To begin to validate the outputs of the predictive model(s) and assess potential 
benefits of the models, by qualitative interaction with JHHC experts. 
 
4.2: Provide preliminary analysis to JHHC care management staff by using the constructs 
and metrics derived in the study, including an analysis of sub-population patient groups 
of interest. 
 
4.2 Study population 
The study population consisted of adult patients with chronic diseases from three Johns Hopkins 
Healthcare (JHHC) health plans who were screened for care management enrollment from 
September 1, 2009 to December 31, 2012. JHHC has three programs: Johns Hopkins Employer 
Health Programs (EHP), Priority Partners (PP), and Johns Hopkins US Family Health Plan 
(USFHP). The study subjects are the adult members of managed care plans who were screened 
for seven types of care management programs, from the EHP, PP and USFHP plans: Population 
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Database 84.6%; Maternity 5.3%; HIV/AIDS 4.1%; Omega Life 3.1%; End Stage Renal 1.5%; 
Asthma 0.8%; Guided Care 0.5%. Following screening the patients were invited to enroll in the 
care management programs and either accepted or declined to enroll. 
 
At the time of the study JHHC had in excess of 250,000 members across multiple plans EHP, 
Priority Partners and US Family Health Plan (JHHC, 2011). EHP is a self-funded health plan for 
employees and families with approximately 50,000 members in the Maryland, Pennsylvania and 
North Virginia area. Priority Partners is one of seven Managed Care Organizations (MCOs) 
providing healthcare to individuals under the Maryland Medicaid children and adult programs. 
The USFHP is a managed care plan contracted with the Department of Defense to serve 
members of the armed services, their families, retirees and survivors. 
 
Care management programs within Johns Hopkins Healthcare utilize screening algorithms to 
identify high risk patients. The algorithms consist of clinical criteria and predictive modeling, 
with general and condition-specific criteria being applied (Murphy, Castro, & Sylvia, 2011). The 
JHHC program makes use of the Adjusted Clinical Groups Predictive Modeling (ACG-PM) 
system, which utilizes administrative claims data to create a risk prediction of individuals with 
high future health expenditures or likelihood of hospitalization (Weiner & Abrams, 2009).  The 
claims data identifies diagnoses and pharmacy recorded for patients, but does not include clinical 
data, such as tests, examinations and findings. 
 
The study setting included all care provided either by the Johns Hopkin Health System (JHHS) 
or other organizations and paid for by JHHC, including primary care, outpatient and inpatient 
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hospital care, retail pharmacy, and special care management intervention programs. The 
population included patients of the three health plans who were over the age of 18, and were 
identified as having a high or moderate need for care management through the JHHC screening 
algorithm or referred for care management. A referral can be made by care providers, clinicians 
within JHHC, or patient self-referral, with clinical screeners checking the screening criteria are 
met for care management. Figure 4-1 JHHC Care Management (CM) Screening Algorithm 
depicts the process JHHC uses to risk stratify members into three groups (High, Moderate and 
Low). Those classified as “high” or “moderate” are offered enrollment into a care management 
program. The JHHC screening uses predictive risk scores (derived from the ACG-PM), with 
“moderate” risk adults with a score approximately in excess of 0.44 and “high” risk over 0.75 in 
the Priority Partners program (PP) during the study period. For the Johns Hopkins Employer 
Health Programs [EHP] the risk score thresholds were approximately 0.18 for ‘moderate’ and 
0.31 for ‘high’ risk adults. Those stratified as “low” or declining enrollment in the program are 










4.3 Study Design 
The study utilized administrative health plan data (i.e. claims and enrollment files), with sub-
groups of patients having additional data available from two other sources: care management 
administrative data and patient self-reported data. The study was a retrospective design, focusing 
on a population of patients screened for care management across a 3-year period (September 
2009 to December 2012). The study consisted of data exploration and the creation of logistic 
regression models, with patient participation (care management program enrollment) as the key 
dependent variable. 
 
A literature review was undertaken to establish currently recognized definitions and related 
concepts, such as self-management, activation, participation, compliance and “readiness to 
change.” These definitions were discussed with clinical and administrative colleagues 
representing a multi-disciplinary team to review relevant constructs, utilizing the PRECEDE-
PROCEED model as a framework (Green & Kreuter, 1999). 
 
Participation markers were created from the administrative data at patient level consistent with 
the definition of participation, as described above. De-identified patient level data were extracted 
for all adult patients, including both those who did or did not enroll in the JHHC Care 
Management program. 
 
4.4 Variables and measures 
For the different phases of the study two main dependent variables were used. First was the level 
of participation, second was the future health expenditures and utilization. A measure of 
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participation was derived from claims and clinical test data (see variable list in appendix 8.1). 
Participation was represented as a dichotomous variable, and also tested as an ordinal or semi-
continuous variable classifying the duration and type of participation. The participation variables 
were developed during the initial stages of the study. As a new measure they were subjected to a 
design, test and refinement process including the testing of construct validity, internal reliability 
(Cronbach’s alpha), responsiveness, validity and interpretability (Juniper, Guyatt, & Jaeschke, 
1996). The future health expenditure variable was an aggregation of costs attributed to individual 
patients over continuous 12-month period, in the second year following the screen process and 
the data utilized as independent variables. 
 
A potential threat to validity of any measures is the reliance on utilization and cost as a 
dependent measure and at the same time measures derived from visits (e.g. intensity of services) 
used as an independent measure. This could create a potential overreliance or circularity in a 
measure, such that historic utilization leads to future utilization directly, rather than being 
determined by patient factors. To mitigate against such potentially confounding effects, 
independent variables were explored for models with and without the inclusion of (prior) cost.  
 
The intermediate control variables include the health risk variables, morbidity measure (ACG), 
age, gender, health plan type, duration of plan eligibility, social/economic status, ethnicity/race 
and Primary Care Provider (PCP) involvement. The characteristics of the enrollment in the care 




For aim 4, to help assess the potential impact of participation in care management, an analytic 
model focusing on expenditure and types of utilization in the succeeding (following screening) 
year was derived. The variables of interest include participation, utilization of medical services, 
and the clinical risk variables created by the ACG-PM system. 
 
The regression coefficients from the logistic regressions used a series of ACG derived morbidity 
measures. These were expected to show the increased effects on patients with multiple and major 
morbidities. The importance of interaction between certain variables was also investigated with 
the expectation of major morbidities concerned with different body systems (disease processes, 
major comorbidities) to show a multiplier effect rather than additive effect. Individual factors, 
provider effects, participation and case management effects were investigated using multi-level 
(random effects) models. The levels of resources utilized by individuals are related to the extent 
of their comorbidities and subsequent health needs. To help mitigate against this effect when 
measuring impact of resource utilization on levels of engagement, the Johns Hopkins ACG 
system was be utilized as a validated approach to help control for morbidity burden (Starfield, 
Weiner, Mumford, & Steinwachs, 1991). 
 
4.5 Methods of data collection 
The subjects were identified via the JHCC members’ database, for all adult patients who had 
either been referred for care management by a clinician, or had been categorized as “high” or 
“moderate” risk through the JHHC care Management screening algorithm. JHHC has access to 
claims data and other personal health information for the members of its three health plans: EHP, 
Priority Partners, US Family Health Plan. The data were obtained electronically for adult 
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members of all three health plan. These electronic files included claims data, care management 
administrative data, plan enrollment dates, patient reported data occurring during the three-year 
time-frame.  
 
Figure 4-2 is a depiction of the data collection process, showing four example patients. The 
individuals for the study were identified from care management (screening) administrative data 
from September 1, 2009 through to December 31, 2012. Patient A was screened for CM in 
November 2009, and enrolled in the CM program. Base level independent variables were taken 
from the ACG data representing claims from the previous 12 months, plan enrollment data, and 
the year 2 outcome measures were derived from November 2010 claims data (12 months 
following enrollment). Patient B, who did not enroll in a CM program, had data collected in the 
same way: claims data from June 2009 to May 2010; declines CM enrollment in June 2010; and 
year 2 outcome measures from June 2011. Patient C had two events during the study time period, 
the first in April 2010 was a decision not to enroll in CM with outcomes measured 12 months 
later, and the second event in October 2010 was a decision to enroll in CM, with a second set of 




Figure 4-2 Data collection timeline 
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4.6 Analytic approach/Analysis Plan  
Concepts and constructs of engagement were derived from a literature review, subjected to 
review and validation by an expert panel and refined. The analysis consists of data exploration, 
production of descriptive statistics, development of measures, development and testing of 
regression models. The development and testing of the predictive models was designed to follow 
the TRIPOD (Transparent reporting of a multivariable prediction model for individual prognosis 
or diagnosis) recommendations and examples, specifically with respect to model comparisons, 
internal and external validation of the models, and describing the model calculations (Collins, 
Reitsma, Altman, & Moons, 2015; Moons et al., 2015). 
 
The data analysis sought to identify factors associated with engagement and create a predictive 
model of likelihood to participate. An initial exploratory data analysis was undertaken to provide 
information on the distribution of independent variables at baseline, 12 months and 24 months. 
The participation variables and enrolment variables were analyzed as dependent variables with 
analysis of covariance with other variables to test for potential confounding due to the quasi-
experimental design of the study (Streiner & Norman, 2008). Logistic regressions were 
undertaken with respect to individual factors (demographic, ethnicity, age, gender, and pre-test 
disease status) to identify those associated with participation and enrollment. Additional logistic 
regression (random effects models) was undertaken after the addition of system level and care 
















Where Psuccess, is the probability of success, e.g. probability of enrollment in care management 
program. βk is the weight (estimate) for dependent variable Xk.  
 
4.7 Analytic Objectives by Aim 
Following each aim study objectives are reiterated and the analytic approach used to address 
each aim is discussed. 
Aim 1 - Defining and Measuring Participation 
Aim 1: To develop an approach for defining and measuring the achievement of patient 
participation in the care management context. 
 
Aim 1 Study Objectives: 
1.1 To derive an operational definition, constructs and a potential measurement 
framework of “patient engagement” in the care management context utilizing the 




1.2 To test the feasibility of deriving alternative measures of participation using available 
secondary data and patient reports from available surveys. 
 
1.3 To undertake measurement analytic activities (including factor analysis) to assess the 
properties of alternative measures (e.g. construct and predictive validity and 
reproducibility). 
 
A literature review was conducted to identify definitions of engagement, and to explore existing 
behavioral and health services research models to derive a summary of concepts and constructs 
potentially related to engagement. The concepts and constructs identified through a literature 
review were subjected to review by clinical and administrative colleagues in JHHC. 
 
The current literature describes patient engagement with respect to concepts of care 
management, self-management and efficacy. Whilst engagement has been associated in the 
literature with patients’ compliance and adherence, these are also provider attributes. The level 
of participation of both patient and provider in the care management process leads to activation 
and empowerment of the patient. Clinical and administrative colleagues provided input to the 
understanding of engagement and the importance and relevance of constructs derived from the 
literature review and their relationships.  
 
Potential measures of participation were derived from the available secondary data, using data 
markers consistent with participation and advice from the expert panel, such as care management 
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enrolment, and duration of enrolment. A data exploration was undertaken to consider the 
completeness and validity of associated data items. Potential measures considered included the 
creation of dichotomous and categorical markers based on single variables, or composite 
measures based on multiple variables as nominal and ordinal scales. 
 
Exploratory Factor Analysis (EFA) was used to identify variables associated with engagement, 
and reduce the number of variables being considered (Joliffe & Morgan, 1992).  This technique 
derives “loadings” for factors associated with level of variation within a measure attributed to 
each distinct factor. An initial model was derived through maximum likelihood estimation, with 
refinement using an analysis of the covariance of the variables. Results were shared with the 
expert panel to access content validity of the identified factors, specifically whether the factors 
cover the attributes and constructs related to engagement. A logistic regression with enrollment 
of individuals as the dependent variable was then used to identify variables associated with 
participation. 
 
Exploratory data analysis and the creation of descriptive statistics informed the utilization of the 
additional administrative data. Particular attention was paid to the completeness and consistency 
of key variables identified from the factor analysis. The measure of participation patterns of 
utilization were categorized to act as intermediate variables to stratify the analyses. The 
categories were both tested as a dichotomous variable consistent with routine and non-routine 
utilizations of health services, and as categorical variables reflecting different patterns of 




The potential measures were subjected to measurement analytics to test construct validity, 
internal reliability (Cronbach’s alpha), responsiveness, validity and interpretability. A further 
stage of expert review was undertaken to test content validity and suggest the addition or 
omission of variables.  
 
Aim 2 - Factors associated with Participation 
Aim 2: To apply these measurement constructs to determine which individual and 
organizational factors are associated with patients’ active participation in their own care; 
 
Aim 2 Study Objectives: 
2.1 To identify individual patient related factors which are independently associated with 
levels of patient participation in care management activities. 
 
2.2 To identify organizational and provider related factors which are independently 
associated with high levels of patient participation in care management activities.  
 
Two methods were used to identify factors associated with participation: Logistic regression; and 
Exploratory Factor Analysis (EFA). 
 
Logistic regression models were initially designed using all available independent variables, with 
the resulting odds ratio for each variable demonstrating the potential association with the 
dependent variable (“participation”). Further refined models were produced by using stepwise 
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regressions to reduce the number of variables. In order to investigate effects that were not 
necessarily at the patient level, multilevel mixed models (i.e. Random Effects Models) were 
utilized. Random effects models were chosen as they incorporate heterogeneity of the effects and 
so do not assume homogeneity (DerSimonian & Laird, 1986).  In this context we were not 
primarily interested in the actual differences in the group level variable (e.g. specific differences 
attributable to each region, or individual nurse care managers), instead we were interested in 
whether between-group differences were significant compared to within-group differences. That 
is, whether the level of participation can be attributed to the care manager level or region level, 
rather than to the patients (Rosner, 2006). Models were created using region and individual care 
managers as group or global effects, these multi-level random effects models were then tested 
against the null model (i.e. the base model not grouped by region or care manager) for 
significance. This was done by comparing the ratio of likelihoods for the respective models (SAS 
procedure COVTEST, (SAS Institute Inc, 2009)). 
 
Exploratory Factor Analysis (EFA) was used to identify variables associated with engagement, 
and to potentially reduce the number of variables being considered (Joliffe & Morgan, 1992).  
This technique derives loadings for factors in describing the level of variation within a measure 
attributed to a given factor. An initial model was derived through maximum likelihood 
estimation, with refinement using an analysis of the covariance of the variables. Results were 
shared with the expert panel to access content validity of the identified factors, specifically 
whether the factors cover the attributes and constructs related to engagement. A logistic 
regression with enrollment of individuals as the dependent variable was derived to identify 




A factor analysis was undertaken with SAS (SAS Institute Inc, 2010) to review the selected 
items, using the approach utilized by Bower and Colleagues (Bower, Mead, & Roland, 2002). 
This approach assumes that are there are unmeasured latent variables (factors) that underlie the 
observed variables. This method was utilized to both explore the reduction of input variables to a 
measure, to inform the theoretical framework and assess the construct validity of a measure 
derived from the observed variables. 
 
Jones described methods including the reduction of variables using factor analysis, with the 
creation of patient clusters based on a Hierarchical Cluster Analysis (Jones, 2009). This approach 
was further adapted using Variable Cluster Analysis (SAS Procedure VarClus) as described by 
Liau and colleagues (Liau, Tan, & Khoo, 2011). In addition to ordinal variables, dummy 
dichotomous variables were created and subjected to cluster analysis to provide potential 
aggregated variables. This led to an iterative approach of combining variable values from the 
cluster analysis. 
 
Aim 3 – Predicting Participation 
Aim 3: To develop a model to predict participation at various stages in the disease 





Aim 3 Study Objectives: 
3.1:  To develop and test a model that will predict which individual patients will likely 
participate at initial and subsequent stages of the care management process. Based on the 
results of analyses in Aims 1 and 2. 
 
3.2: To assess the independent relationship between patient participation and outcomes 
such as health expenditures, and health services utilization. 
 
The analysis consisted of exploratory data analyses, production of descriptive statistics, 
development and testing of regression models, and the application and testing propensity score 
matching. Two basic types of regression models were created, linear and logistic regression. The 
respective models were validated using split sample model validation.  
 
Exploratory data analysis and the creation of descriptive statistics were derived to inform the 
utilization of the claims and administrative data. Particular attention was paid to the 
completeness and consistency of key variables identified from the factor analysis, thus ensuring 
that such variables were relevant to the population and minimize susceptibility of the variables to 
selection bias. For example, whether such variables had valid values recorded for most of the 
study population, rather than being missing or incomplete. Sub-population characteristics (multi-
morbidity complexity, and screening characteristics) were categorized to act as intermediate 
variables to stratify the analyses. The categories were analyzed across all three health plan sub-
groups, for patients enrolled and not-enrolled in case management, for outcomes in the second 
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year following screening. The second year outcome measures assessed were mean annual health 
expenditure, mean number of hospitalizations, and emergency room visits. 
 
Previous studies of healthcare costs identified the analytic challenge of the cost distribution 
being highly right skewed and following a lognormal distribution (Diehr, Yanez, Ash, 
Hornbrook, & Lin, 1999). To help address this Log transformed charges are sometimes used for 
the purposes of models for risk stratification for disease management programs (Li et al., 2005).  
 
To help assess variables to potentially be added to the logistic model the likelihood ratio test was 
applied to candidate models. The creation of parsimonious multiple linear regression models 
would be undertaken as using forward and backward stepwise regression. Selected variables for 
models were assessed for collinearity and whether the assumptions of any regression models 
hold. Interaction terms were added to the models to test for significant effect modification with 
models compared using the Akaike information criterion (AIC) (Bozdogan, 1987). Receiver 
Operating Characteristic (ROC) analysis was used to identify optimal models with respect to 
sensitivity and specificity. 
 
A Score model was derived from the final model, by creating a for each of the input variables 
using the points method described by Sullivan and Colleagues (Sullivan, Massaro, & D'Agostino 
RB, 2004) originally developed by the Framingham Heart Study. A score is calculated for each 
variable in the model by dividing the regression estimate by a constant value representing the 
value of a single unit, and rounding to the nearest integer. This tool was developed to aid 




While testing the outcomes following case management enrollment, it is necessary to reduce the 
risk of selection bias where possible to ensure that the observed outcomes are associated with the 
enrollment. Ideally a study would be randomized but in an observational study within an 
operational setting randomization of cases to “treatment” and “control” groups is not possible. 
The propensity score matching (PSM) approach was therefore used as a retrospective proxy for 
randomization to help control for bias. When observing the outcomes for patients who have 
either enrolled (“treatment”) or not enrolled (“control”) in to care management, there may be 
differences in these outcomes, but we cannot necessarily conclude that these differences in 
outcomes are as a result of the care management or because of inherent differences in the 
characteristics of the two populations (Coca-Perraillon, 2007; Kleinman, 2010). Propensity score 
matching (PSM) identifies patients that have similar characteristics, e.g. similar probability of 
enrollment, and therefore similar independent variable values such as age, gender, and morbidity 
pattern. A key assumption in the PSM approach is conditional independence. This is that there 
are is a given set of covariates which are observable, not affected by the intervention, and the 
outcomes are independent of the assignment to ‘treatment’ or ‘control’ (Caliendo & Kopeinig, 
2008). Specifically, any variables that affects an individual enrolling in care management and 
subsequent outcomes, are included in the model, and therefore, there are no unobserved variables 
affecting enrollment. The analysis was then performed on the matched pairs of cases, on the 
assumption that the enrolled and non-enrolled matched cases will have similar underlying 
characteristics based on the sub-populations having similar distributions for the probability of 




In order to implement PSM, the PSMatching SAS macro developed by Coca-Perraillon was 
used. This macro searches for and creates a table of treatment-control pairs. The “Nearest 
Available Neighbor” and “Caliper” matching methods were used without replacement (i.e. 
controls were only used once), where all of the cases are randomly sorted. PSM was carried out 
separately for each of the three plans, first using Nearest Neighbor matching and then using the 
Caliper method. In the Nearest Available Neighbor method for each treatment case the control is 
chosen that had the closest propensity score (probability of enrollment in case management), this 
method ensures a control match for each treatment case, but does not ensure that the absolute 
difference in score are close. The Caliper method allows for a minimum absolute difference in 
prevalence to be specified, but does result in data loss where a match cannot be found within the 
specified absolute difference (Coca-Perraillon, 2006). Caliper matching has been found to have 
less bias than Nearest Neighbor and other propensity matching methods, but Nearest Neighbor 
produces better estimates due to producing a greater number of matched pairs (Austin, 2014). 
 
Aim 4 - Initial Implementation and Assessment 
Aim 4: To create and begin the dissemination of tools for the measurement of care management 
participation across the study populations to help improve the care management process. 
 
Aim 4 Study Objectives: 
4.1:  To begin to validate the outputs of the predictive model(s) and assess potential 




4.2: Provide preliminary analysis to JHHC care management staff by using the constructs 
and metrics derived in the study, including an analysis of sub-population patient groups 
of interest. 
 
The measure of participation and predictive model are to be compared to the results of applying 
the existing algorithm to a test population of patients. A performance comparison was 
undertaken using the c-statistic, and measures of sensitivity, specificity and positive predictive 
value (PPV) (Murphy et al., 2011). Sensitivity and specificity measures are inversely related and 
so the maximization of sensitivity (increasing likelihood of selecting a true positive, reducing 
false negatives, lowering type II errors) will typically lead to a reduction in specificity 
(increasing type I errors). The number of individuals selected by the algorithm should also be a 
consideration with respect to the capacity of case managers to review.  
 
The outcomes analysis, using Propensity Score Matching was broken down by sub-population 
patient groups derived from the exploratory factor analysis and variable cluster analysis, and 
provided to colleagues in JHHC. Where necessary, refinement of theses sub-population analyses 







The following chapter describes the characteristics of the study populations, the results of the 
investigation of factors that underlie participation in the care management programs, the 
derivation and application of models to predict participation, and the measurement of patients’ 
outcomes following participation or non-participation in care management. 
 
5.1 Description of Study Population 
A total of 18,413 members were screened for seven care management programs by JHHC from 
September 1, 2009 to December 31, 2012. The members had one or multiple care management 
records providing 31,359 records. Members with duplicate CM records (n= 141) were deleted. 
The requirement that the cases could be linked to the longitudinal claims records resulted in a 
further loss of 249 members. After those exclusions the initial study sample consisted of 18,023 
members with 29,934 separate CM records. The care management records indicate whether a 
member was enrolled or not (“unmanaged”) in one or more care management programs.  
 
The care management records were linked to the claims data based on the month of analysis. 
Specifically, from the date of a decision to enroll or not, the outcome was linked to the claims 
records for the immediately preceding 12 months. Where the decision of the patient to enroll or 
not to enroll was missing (only occurred for moderate risk, “level 2” patients) these claims 
records were censored from the final data set (see appendix 8.3.1 for an analysis of the missing 
data). Care management enrollment outcomes were present for all high risk (JHHC “Level 1”) 
screened patients, but missing for some moderate risk (JHHC “Level 2”) patients. For members 
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screened from the Priority Partners plan there were 5451 records without a recorded outcome, 
and 2871 records with an outcome. It was assumed that the members without an outcome were 
not followed up during the screening period, but were subsequently reentered into the screening 
algorithm in the succeeding month. This assumption was confirmed by the case management 
team. Figure 5-1 presents the consort diagram, representing the process of selecting the final 
study sample based of record availability. The final sample consisted of 11364 members with 






3 Health Plans 
Screening High & Moderate 
Risk (Level 1 & 2) 
Algorithm / Referral 
Sept 2009 - Dec 2012 
18413 Members  
(31359 CM records) 
141 Duplicate Records 
249 Not linked to ACG 
monthly file 
11364 members 





6269 members Missing 
Outcome (Level 2 only) 




5.1.1 Study population summary 
Table 5-1 shows the demographic characteristics for each study member at the time of their only 
(or initial) case management screening (total population of 11,364). The results are presented for 
each of the three health plans separately.  
 
The final study population was 64.6% female (EHP 63.7%, PP 68.8, USFHP 52.8%), with an 
average age of 49.9 years (EHP 50.1, PP 44.0, USFHP 68.2). They were predominantly 
multimorbid with a mean number of chronic conditions of 4.5 (EHP 3.4, PP 4.4, USFHP 6.2), 
28.4% of the members being classified as frail (EHP 19.0, PP 31.6, USFHP 31.0). The condition 
across all sub-groups was: diabetes 38.4%; asthma of 36.9%; lipidemia 45.2%; hypertension 
70.5%; and depression 40.2%. 
 
Following screening, 40.2% of the members invited, enrolled in a case management program 
(EHP 38.3%, PP 42.5%, USFHP 35.9%) with 85.8% of this “joining” sub-group remained 
enrolled for at least 6 months (EHP 89.8%, PP 80.8%, USFHP 96.1%), and 67.9% for at least 12 
months (EHP 76.6, PP 60.0%, USFHP 80.9%). The proportion of Medicaid plan members 
enrolling in care management programs appeared to be inversely related to the number of 
chronic conditions and Major Aggregate Diagnosis Groups (ADG), both measures of 
multimorbidity. Members with no chronic conditions enrolled at a rate of 58.74%, which was 
reduced to a rate of 33.44% for those with six chronic conditions (see Figure 5-2). Similarly, 
Figure 5-3 shows that patients with no Major ADGs had a care management enrolment rate of 
58.53%, but this is reduced to 33.51% for patients with four Major ADGs. 
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US Family Health 
(DoD) 
N 2,836  6,478  2,050  
Female 0.6368 (0.4810) 0.6879 (0.4634) 0.5283 (0.4993) 
Region 
  Baltimore City 0.6227 (0.4848) 0.4555 (0.4981) 0.2195 (0.414) 
  Baltimore County 0.2542 (0.4355) 0.1047 (0.3061) 0.3805 (0.4856) 
  Eastern Shore 0.0116 (0.1073) 0.2187 (0.4134) 0.0288 (0.1672) 
  Southern 0.0638 (0.2445) 0.1511 (0.3582) 0.1361 (0.343) 
Age at Screening 50.0846 (12.172) 43.9548 (12.218) 68.2210 (13.022) 
Age 65+ 0.0917 (0.2886)   0.6337 (0.4819) 
Race 
  Black   0.5435 (0.4981) 0.2361 (0.4248) 
  White   0.3692 (0.4826) 0.7195 (0.4493) 
  Other   0.0282 (0.1657) 0.0317 (0.1753) 
Chronic Conditions 3.4115 (2.4194) 4.4461 (3.0781) 6.1580 (3.0359) 
Major ADGs 1.6266 (1.4295) 2.5695 (1.7426) 2.7673 (1.5242) 
Frailty 0.1904 (0.3927) 0.3163 (0.4651) 0.3102 (0.4627) 
Probability IP Hospitalization 0.1384 (0.1253) 0.2683 (0.2013) 0.2986 (0.1797) 
Rescaled Total cost index 5.2907 (4.5242) 8.5502 (6.4152) 4.1310 (2.5299) 
Generic Drug count 10.2405 (6.2030) 14.4923 (8.8450) 14.1751 (6.9260) 
Unique Provider count 4.5732 (2.7407) 4.4057 (2.9845) 5.2855 (2.7871) 
Specialty count 3.7920 (2.0359) 3.4906 (2.1194) 4.2411 (2.0378) 
Plan Enrollment   
  Enrolled > 6mth 0.8977 (0.3030) 0.8078 (0.3941) 0.9610 (0.1937) 
  Enrolled > 12mth 0.7659 (0.4235) 0.5997 (0.4900) 0.8088 (0.3934) 
Condition Prevalence       
  Asthma 0.2486 (0.4323) 0.4392 (0.4963) 0.3176 (0.4656) 
  Rheumatoid Arthritis 0.0511 (0.2203) 0.0344 (0.1823) 0.0600 (0.2375) 
  Congestive Heart Failure 0.0811 (0.2730) 0.1425 (0.3496) 0.2234 (0.4166) 
  Depression 0.3078 (0.4617) 0.4560 (0.4981) 0.3610 (0.4804) 
  Diabetes 0.3593 (0.4799) 0.3572 (0.4792) 0.5029 (0.5001) 
  Lipidemia 0.4580 (0.4983) 0.3606 (0.4802) 0.7298 (0.4442) 
  Hypertension 0.6714 (0.4698) 0.6670 (0.4713) 0.8727 (0.3334) 
  Ischemic Heart Disease 0.0832 (0.2763) 0.1096 (0.3124) 0.2693 (0.4437) 
Case Management Participation 
  Enroll in CM program 0.3829 (0.4862) 0.4248 (0.4944) 0.3590 (0.4798) 
  CM Program > 12mths 0.4609 (0.4987) 0.1642 (0.3705) 0.2407 (0.4279) 
Mean (standard deviation) 




Figure 5-2 Care Management Enrollment Rate by Chronic Condition Count: Medicaid 
Plan 
 
Note: Total n across all JHHC plans = 11,364 
Figure 5-3 Care Management Enrollment Rate by Major ADG: Medicaid Plan 
 








































































The next three sections present analyses of factors related to CM program enrollment, separately 
for each health plan. 
5.1.2 Medicaid Plan population: Priority Partners 
Table 5-2 presents the results of the logistic regression on the care management program 
enrollment outcome. The data related to initial Case Management records for Priority Partners 
members who were screened as either high or moderate risk (level 1 or level 2). 
 
For this Medicaid population the initial probability of a patient enrolling in a case management 
program after screening was 42.5%. Subsequent outcomes appeared to be conditional on the first 
outcome, such that the probability of a patient enrolling a second time, following an initial 
enrollment was 88.1%, while the probability of enrolling after initially declining to enroll was 
much lower at 27.2% (the odds ratios for these outcomes are shown in Table 8-2 and Table 8-3). 
 
Statistically significant increases in enrollment were produced where the odds ratio was greater 
than one, i.e. a higher probability of members enrolling in a care management program than the 
base case. A significantly higher odds ratio occurred for black members compared to white, and 
whether referred or only screened via the JHHC algorithm. For black patients there was almost a 
48% increase in the rate of enrollment compared with white patients (holding other variables the 
same), indicated by an odds ratio (OR) of 1.478 with a 95% confidence interval (CI) of 1.297 to 
1.684 (OR 1.478, CI 1.297- 1.684). Other increases in enrollment were associated with members 
who had been referred for case management (OR 2.243, CI 1.838 - 2.737), and those with higher 
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numbers of specialists seen (OR 1.099, 1.031 - 1.172). These last two effect may be the result of 
increased activity by and with providers. 
 
Significant reduction in care management enrollment was associated with a range of variables 
related to increased multimorbidity (or comorbidity), and age. Older members (aged 35-64) were 
24% less likely to enroll than younger (aged 18-34) holding other variables the same (OR 0.761, 
CI 0.659 - 0.878). An increase in the number of chronic conditions, ADGs and generic drug 
count also showed reductions in care management enrollment. Up to 53% reduction in 
enrollment for 6 or more chronic conditions compared to none (OR 0.474, CI 0.335 - 0.671), and 
65% for 4 or more major ADGs (OR 0.445, CI 0.344 - 0.576). These results would suggest that 
with increase in multimorbidity, a member was less likely to enroll in a case management 
program. Two specific conditions showed significant reductions in the rate of enrolment, 
rheumatoid arthritis (OR 0.717, 0.528 - 0.972) and hypertension (OR 0.786, 0.684 - 0.904). 




Estimate 95% CL 
Gender Male vs Female 0.918 0.807 1.045 
Region    
  Central vs Baltimore City 0.749 0.472 1.188 
  County vs Baltimore City 0.778 0.64 0.946 
  Eastern Shore vs Baltimore City 0.894 0.766 1.042 
  Other vs Baltimore City 0.595 0.302 1.171 
  Southern vs Baltimore City 1.008 0.851 1.193 
  Western vs Baltimore City 0.849 0.644 1.119 
Age 35-64 (base 18-34) 0.761 0.659 0.878 
Race    
  Black vs White 1.478 1.297 1.684 





Estimate 95% CL 
  Unspecified vs White 1.162 0.900 1.499 
Primary Care Provider Multiple vs 1 0.605 0.523 0.7 
Risk level (vs Level 2 - Moderate)   
  Level 1 - High 2.301 2.002 2.645 
  Other 1.769 1.444 2.168 
Chronic Conditions (vs none)   
1 0.735 0.543 0.996 
2 0.696 0.511 0.947 
3 0.654 0.476 0.900 
4 0.641 0.461 0.893 
5 0.599 0.424 0.846 
  6+ 0.474 0.335 0.671 
Major ADG (vs none)    
1 0.658 0.524 0.826 
2 0.656 0.517 0.832 
3 0.544 0.423 0.699 
4 0.445 0.344 0.576 
Frailty 1.015 0.896 1.150 
Referral into CM 2.243 1.838 2.737 
Generic drug count 0.987 0.978 0.996 
Unique Provider Count 0.976 0.934 1.020 
Number of Specialties 1.099 1.031 1.172 
No Generalist 0.785 0.601 1.027 
Condition    
  Asthma 0.956 0.846 1.081 
  Rheumatoid Arthritis 0.717 0.528 0.972 
  Congestive Heart Failure 1.003 0.846 1.190 
  Depression 0.914 0.807 1.035 
  Diabetes 0.943 0.828 1.074 
  Disorders of Lipid Metabolism 1.010 0.877 1.163 
  Hypertension 0.786 0.684 0.904 
  Ischemic Heart Disease 0.923 0.757 1.124 
Enrollment in Health Plan    
  6 months 0.944 0.781 1.140 
  12 months 1.146 0.997 1.318 
Bold indicates factor significant at 95% level 
Medicaid plan, Screened for Care Management High and Moderate Risk,  
n = 6029, probability = 0.4254 
Baseline odds for a Female aged 18-34, White, Baltimore City = 0.8534  




5.1.3 Effects of Region and Care Manager 
To investigate whether region and the care managers exhibited a global effect distinct from the 
patient level effects, random effects models were used. The multi-level random effects models 
were tested against the null model (i.e. the base model) for significance, by comparing the ratio 
of likelihoods for the respective models (SAS procedure COVTEST). Table 5-3 below shows the 
three multi-level models; the first using region as a global effect, the second using care manager, 
the third model used both region and care manager. The covariance tests for the medicaid cohort, 
shown in Table 5-1, did not have any significant results for any of the models (respective 
probabilities of 0.2095, 0.1333 and 0.1825). Therefore, for the Medicaid plan data the null 
hypothesis of no random effects was accepted. It was therefore concluded that the region and 
care manager global effects were not significant and the patient level effects found above 
represented independent explanatory factors. 
 
Table 5-3 Tests of Covariance Parameters Based on the Residual Pseudo-Likelihood, on 
Three Nested Models, Medicaid plan data 
Variable 




Pr > ChiSq 
Region 26448 0.65 0.2095 
Care Manager 21862 1.23 0.1333 
Region (Care Manager) * 21912 0.82 0.1825 
Ho: No random effects. 
P-value based on a mixture of chi-squares. 
* nested model: level 1 Patient, level 2 Care Manager, level 3 Region 
 
While the multi-level models were significant, the odds ratios showed a pattern consistent with 
the single level models. In Table 5-4 selected odds ratios are presented for the multi-level models 
(see appendices 8.3.1 for full results). These are consistent with the base model and earlier 
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results. The odds ratios show that younger aged patients, and patients with lower levels of 
multimorbidity (Major ADGs), are more likely (holding other effects the same) to enroll in a care 
management program than older patients and those with higher levels of multimorbidity. For 
younger patients the odds ratios were 1.401, 1.296 and 1.325 for the three nested models.  The 
odds ratios for multimorbidity show a steady decline for all three models from patients with no 
Major ADGs (less complex) to those with four or more (most complex), with the odds ratios 
ranging from 1.926 to 1.223, 1.759 to 1.161 and 1.939 to 1.224 for the three models. The multi-
level models all showed that there was higher enrollment amongst black patients compared to 




Table 5-4 Impact of factors on member’s joining (yes/no) CM program: Selective List of 





Care Manager Model    
  Age 18-34 1.401 1.210 1.622 
  Black vs White 1.347 1.186 1.530 
  ADG 0 v 4+ 1.926 1.478 2.509 
  ADG 1 v 4+ 1.418 1.167 1.724 
  ADG 2 v 4+ 1.511 1.269 1.800 
  ADG 3 v 4+ 1.223 1.033 1.448 
    
Region Model    
  Age 18-34 1.296 1.126 1.492 
  Black vs White 1.419 1.253 1.607 
  ADG 0 v 4+ 1.759 1.371 2.256 
  ADG 1 v 4+ 1.305 1.083 1.572 
  ADG 2 v 4+ 1.321 1.120 1.558 
  ADG 3 v 4+ 1.161 0.990 1.362 
    
Region (Care Manager) Model*    
  Age 18-34 1.325 1.137 1.544 
  Black vs White 1.370 1.202 1.561 
  ADG 0 v 4+ 1.939 1.477 2.545 
  ADG 1 v 4+ 1.438 1.174 1.761 
  ADG 2 v 4+ 1.528 1.278 1.827 
  ADG 3 v 4+ 1.224 1.032 1.451 
95% CI, confidence interval 
* nested model: level 1 Patient, level 2 Care Manager, level 3 Region 






5.1.4 Employee Health Plan 
The results of the linear regression on the Employee Health Plan population, where the 
dependent variable was enrolling in the Care Management program, are presented in Table 5-5. 
No significant regional effects were shown, but lower enrolment was associated with members 
aged 65 years and older (OR 0.525, CI 0.348 - 0.791). Lower enrolment was also observed as 
multimorbidity increased; shown by the consistent reduction in the odds ratios as the number of 
chronic conditions increased and the number of major ADGs increased. A patient with two 
chronic conditions showed a 36% reduction in the rate of enrollment (adjusting for other factors) 
compared to a patient with no chronic conditions, and a patient with 4 chronic conditions showed 
a further reduction of almost 49%. 
 
Significant increases in the rate of enrollment was exhibited for members with one primary care 
physician (compared to many), those with frailty, who had been referred, or with increased 
numbers of specialty physicians seen. Referral showed the highest effect with patients who were 
referred being more than 300% more likely to enroll adjusting for other factors (OR 3.192, CI 
2.235 - 4.559). Those who were frail showed a 42% increase in enrollment (OR 1.424, 1.147 - 
1.767). 
 
Higher rates of enrollment were observed for four specific conditions, asthma (OR 1.225, CI 
1.000 - 1.501), diabetes (OR 1.404, CI 1.162 - 1.697), hypertension (OR 1.554, CI 1.244  - 








Estimate 95% CL 
Gender M vs F 0.910 0.753 1.101 
Region    
  Central vs Baltimore City 1.201 0.277 5.210 
  County vs Baltimore City 0.979 0.804 1.192 
  Eastern Shore vs Baltimore City 0.920 0.420 2.019 
  Other vs Baltimore City 1.132 0.681 1.881 
  Southern vs Baltimore City 0.835 0.559 1.246 
  Western vs Baltimore City 0.551 0.257 1.181 
Age (base 18-34)    
  Age 35-64 0.984 0.752 1.287 
  Age 65+ 0.525 0.348 0.791 
Primary Care Provider (Base >1)    
  No PCP 1.835 0.845 3.984 
  1 PCP 2.305 1.056 5.029 
Chronic Conditions (vs none)    
  1 0.837 0.572 1.226 
  2 0.642 0.438 0.941 
  3 0.746 0.501 1.112 
  4 0.513 0.335 0.785 
  5 0.447 0.282 0.711 
  6+ 0.407 0.252 0.658 
Major ADG (vs none)    
  1 0.626 0.491 0.798 
  2 0.536 0.406 0.707 
  3 0.497 0.353 0.700 
  4 0.720 0.498 1.042 
Frailty Y vs N 1.424 1.147 1.767 
Referral into CM 3.192 2.235 4.559 
Generic Drug Count 0.959 0.940 0.978 
Unique Provider count 0.945 0.872 1.025 
Specialty count 1.122 1.008 1.250 
No Generalist Seen Y vs N 1.126 0.734 1.729 
Condition    
  Asthma 1.225 1.000 1.501 
  Rheumatoid Arthritis 0.771 0.517 1.151 





Estimate 95% CL 
  Depression 0.895 0.735 1.091 
  Diabetes 1.404 1.162 1.697 
  Disorders of Lipid Metabolism 0.821 0.673 1.002 
  Hypertension 1.554 1.244 1.942 
  Ischemic Heart Disease 1.458 1.055 2.015 
Enrollment in Health Plan    
  6 months 1.300 0.867 1.950 
  12 months 0.841 0.658 1.076 
Bold indicates factor significant at 95% level 
EHP, Screened for Care Management High and Moderate Risk, 
n = 2692, probability = 0.3763 
Baseline odds for a Female aged 18-34, White, Baltimore City = 0.2160 





5.1.5 US Family Health Plan 
The results of the linear regression on the US Family Health Plan (DoD) population, where the 
dependent variable was enrolling in the Care Management program are presented in Table 5-6. 
Unlike the other populations in the study significant effects were shown for specific regions. 
Three regions showed higher rates of enrollment than Baltimore City (the baseline). These were 
Central (OR 2.386, CI 1.228 - 4.638), Eastern Shore (OR 1.828, CI 1.012 - 3.301), and Southern 
(OR 1.605, CI 1.144 - 2.251). 
 
In contrast to the Medicaid population, no significant race effect was shown (OR 1.015, CI 0.797 
- 1.291). The USFHP population were also different as it showed no significant effect associated 
with increased morbidity (Chronic conditions or Major ADG). Referrals however showed an 
increased rate of enrollment over those not enrolled of 180% (OR 1.810, CI 1.355 - 2.419). 
 
Condition specific effects were significant for only two conditions, asthma and diabetes. Similar 
to the Medicaid population these both had lower rates of enrollment, asthma (OR 0.624, CI 0.495 
- 0.786), and diabetes (OR 0.550, CI 0.445 - 0.680). 
 
Significant effects were also associated with the duration of enrollment in the plan. For members 
with at least 12 months of continuous plan enrollment prior to screening, enrollment for care 
management was 55% higher adjusting for other factors (OR 1.556, 1.173 - 2.064), while those 
with at least 6 months of continuous plan enrollment the care management enrollment was 









Estimate 95% CL 
Gender Male vs Female 0.812 0.659 1.001 
Region    
  Central vs Baltimore City 2.386 1.228 4.638 
  County vs Baltimore City 1.25 0.954 1.638 
  Eastern Shore vs Baltimore City 1.828 1.012 3.301 
  Other vs Baltimore City 1.152 0.801 1.656 
  Southern vs Baltimore City 1.605 1.144 2.251 
  Western vs Baltimore City 1.213 0.822 1.79 
Age (base 18-34)    
  Age 35-64 0.98 0.476 2.018 
  Age 65+ 0.914 0.439 1.902 
Race    
  Black vs White 1.015 0.797 1.291 
  Other vs White 0.861 0.493 1.504 
  Unspecified vs White 1.277 0.562 2.9 
Chronic Conditions (vs none)    
  1 1.378 0.445 4.266 
  2 1.364 0.458 4.059 
  3 1.891 0.637 5.613 
  4 1.591 0.537 4.712 
  5 1.415 0.474 4.223 
  6+ 1.316 0.439 3.951 
Major ADG (vs none)    
  1 0.698 0.393 1.238 
  2 0.960 0.542 1.699 
  3 0.737 0.41 1.323 
  4 0.921 0.509 1.669 
Frailty Y vs N 1.188 0.959 1.471 
Referral into CM 1.810 1.355 2.419 
Generic Drug Count 0.980 0.962 0.999 
Unique Provider count 1.054 0.981 1.132 
Specialty count 0.969 0.877 1.069 
No Generalist Seen Y vs N 3.312 0.931 11.779 





Estimate 95% CL 
  Asthma 0.624 0.495 0.786 
  Rheumatoid Arthritis 0.702 0.458 1.074 
  Congestive Heart Failure 0.996 0.777 1.277 
  Depression 1.124 0.9 1.404 
  Diabetes 0.550 0.445 0.680 
  Disorders of Lipid Metabolism 0.880 0.69 1.124 
  Hypertension 1.106 0.799 1.532 
  Ischemic Heart Disease 1.228 0.961 1.567 
Enrollment in Health Plan    
  6 months 0.438 0.253 0.759 
  12 months 1.556 1.173 2.064 
Bold indicates factor significant at 95% level 
USFHP, Screened for Care Management High and Moderate Risk,  
n = 2028, probability = 0.3585   
Baseline odds for a Female aged 18-34, White, Baltimore City = 
0.6284Abbreviations: CL, confidence limit 
 
5.1.6 Summary of initial analyses 
These initial analyses found a number of individual level factors associated with a patient’s 
likelihood to enroll or not to enroll in a case management program. Patients with higher 
multimorbidity, and older patients, holding other effects the same, were associated with a 
decreased propensity to enroll in care management programs.  
 
Higher enrollment in the care management programs (holding other effects constant) was shown 
therefore in younger and less multimorbid patients. Higher propensity to enroll was also found in 
black patients compared to white patients for the Medicaid plan, while the USFHP plan did not 
show a significant race effect.  For all plans, members who had been referred to care 
management by a physician or other clinicians also showed increased enrolment. Condition 
specific effects were found, but these varied between the three health plan sub-populations, both 
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with respect to which conditions showed significant enrollment effects, and also whether the 
condition was associated with increased or decreased enrollment rates. 
 
In order to test if the effects found were at the patient level and might be due to higher level 
effects (e.g. region), multilevel models were tested on the Medicare population. The multilevel 
(random effects) models were created to test if there were regional and care manager global 
effects. These global effects were not found to be significant, and therefore patient level effects 
were confirmed. Furthermore, the multilevel effects models also produced results which 
generally confirmed those found with the original single level model. Specifically, enrolment 
was again found to be associated with younger patients (holding other factors constant), black 




5.2 Patient Participation Risk Models 
The following sections describe the creation of risk models to predict member enrolment in care 
management program following outreach. The initial approach was to create a model using 
existing claims data using the factors identified in the preceding sections. Further models were 
then created using exploratory factor analysis using additional patient survey data. 
 
5.2.1 Models for predicting participation in case management programs 
Two approaches were used to train and validate the initial models. The main approach was a split 
half validation, where the regression model was trained on a random sample of 50% of the data 
across all plans, and validated on the other 50%. An alternative method, was also examined, by 
training the model on the Medicaid population data and then validate on the other two plans, 
with variants using the other two planes. The alternative (plan based) method was found to 
achieve inconsistent results across the three plans, compared to the more consistent results that 
the split-half validation model achieved. 
 
5.2.2 Split half validation 
The entire data set was randomly assigned to one of two sub sets, such that approximately 50% 
of the data was assigned to each. A training data set was used to derive the model coefficients, 
and the second data set was used for validation. The validation results are shown in Table 5-7 for 
the basic comparator model (age, gender only), initial model (six variables), the final model (16 
variables), and the Score model derived from the final model. This split-half model produced a 
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C-Statistic for the validation data of 0.6206 for the first model compared to 0.6318 on the 
training data. This parsimonious model had just six variables: gender, age; Major ADG count, 
referral, plan enrollment ≥ 6 months, and plan enrollment ≥ 12 months. The initial model 
compares favorably with a basic model which only used gender and age, and a C-Statistic on the 
validation data of 0.5729. Iterative improvements were made to the model by adding variables, 
performing step-wise regressions to arrive at optimized models, and consolidating dependent 
variables to ensure that variables were retained that formed a group, for example, retaining all 
Chronic Condition count variables. The final model contained 16 variables, with a C-Statistic on 
the validation data of 0.6327 (0.6622 on the training data). The variables with multiple values 
were converted in to dichotomous variables to facilitate an easier conversion in to a score, using 
the SAS SCORE function. The classification of semi-continuous variables in to separate 
dichotomous variables (such as Chronic Condition count, and Major ADG count) also allows for 
non-linear weighting to be applied. For example, using Major ADG as a continuous variable 
would have meant that each additional increase in the number of Major ADGs (holding other 
variables constant) would result in the same proportionate change in risk, whereas classification 
of the variables allowed different weightings to be derived for each separate count. The table also 
shows the C-Statistics for the validation data divided between the three plans. The Medicaid plan 
and the Employee plan had similar results of 0.6358 and 0.6442 respectively, with the 





Table 5-7: Predictive Models performance, Split half validation: Random 50% training 
data, 50% validation data set 
   Model C-Statistic 
 Population / Plan N Outcome Model 0 Model1 Model7 Score 
Training Data 5701 0.4031 0.5729 0.6318 0.6622 0.6622 
Validation Data 5663 0.4019 0.5754 0.6206 0.6327 0.6326 
    Medicaid Plan 3249 0.4217 0.5842 0.6389 0.6358 0.6357 
    Employee Plan 1390 0.3871 0.5678 0.6275 0.6442 0.6442 
    DoD Plan 1024 0.3594 0.5280 0.5612 0.6209 0.6206 
Outcome: Patient Enrolled in Case Management program following screening 
Model 0 independent variables: Gender, Age 
Model 1 independent variables: Gender, Age, Major ADG count, Referral, Plan Enrollment ≥ 6 months, 
Plan Enrollment ≥ 12 months 
Model 7 independent variables:  Gender, Age, Primary Care Provider, Major ADG count (max 4), Chronic 
Count (max 6), Frailty, Referral, Generic Drug count, Selected Conditions 
 
The Score model was derived from the final model, using an adapted form of the method 
described by Sullivan and colleagues (Sullivan et al., 2004), by dividing each estimate by a 
constant value representing the value of a single unit, and rounding to the nearest integer. The 
estimate for the variable age was chosen as this constant. The C-Statistics for the score model 
were similar to those of the final model as expected, with any differences attributed to the effect 
of rounding the model scores to integers. 
 
The validation statistics for the final model are given from the validation data, for selected cut-
points in Table . This shows that if a cut-point of 0.4 were chosen with all patients selected with 
a probability of 40% or more, 2794 would be chosen, resulting in Positive Predictive Value of 
49.9% (half of the chosen patients would enroll in case management, true-positive cases), a 
sensitivity of 61.2% (proportion of all true-positives in the selection), and a specificity of 58.6% 




Table 5-8 Validation of predictive model: Performance for selected cut points 
N 
Cut Point 
Probability PPV Sensitivity Specificity 
% of 
Data 
230 0.6 73.5 7.4 98.2 4% 
1143 0.5 57.4 28.8 85.6 20% 
2794 0.4 49.9 61.2 58.6 49% 
4665 0.3 43.0 88.0 21.4 82% 
5461 0.2 40.6 97.5 4.3 96% 
Validation data, n = 5663, C-Statistic 0.6327 
Dependent variable: Patient Enrolled in Case Management program following 
screening 
independent variables:  Gender, Age, Primary Care Provider, Major ADG count 
(max 4), Chronic Count (max 6), Frailty, Referral, Generic Drug count, Selected 
Conditions 
PPV – Positive Predictive Value 
 
The ROC curves for the three models are shown in Figure 5-4. This figure shows the curve of all 
values of Sensitivity for the models plotted against the inverse of the sensitivity. The area under 
each curve represents the C-Statistic, with the models with the greatest explanatory power curing 
towards the upper-left quadrant of the graph. The straight diagonal line represents the values 
achieved by a ‘no better than chance’ model, with all of the models lying to the left showing 




Figure 5-4 Comparison of ROC Curves: 50% Split-half Validation data set 
 
 
To facilitate an easier adoption of the model. The model was created using logit variables to 
easier facilitate the creation of a score. The score was calculated by dividing each variable 
estimate by the value of the Age at screening estimate, which was the variable chosen to be the 









1 + 𝑒−0.3878 + 0.0091×∑𝑠𝑐𝑜𝑟𝑒
 
 
For example, an individual aged 55 (score -55), with 1 ADG (-33), 1 chronic condition (8), who 













If the same patient had 4 ADGs (-45), and 6 Chronic Conditions (-40) they would have a total 
score of -33 and a probability of 0.33. 
 
Table 5-9 shows the estimates and odds rations for the final model. The estimates were converted 
in to a score to facilitate an easier adoption of the model. The model was created using logit 
variables to easier facilitate the creation of a score. The score was calculated by dividing each 
variable estimate by the value of the Age at screening estimate, which was the variable chosen to 









1 + 𝑒−0.3878 + 0.0091×∑𝑠𝑐𝑜𝑟𝑒
 
 
For example, an individual aged 55 (score -55), with 1 ADG (-33), 1 chronic condition (8), who 













If the same patient had 4 ADGs (-45), and 6 Chronic Conditions (-40) they would have a total 










95% CL Score 
Intercept -0.3878     
Gender Female vs Male 0.2438 1.276 1.127 1.446 27 
Age at Screening (in years) -0.0091 0.991 0.986 0.996 -1 
Primary Care Provider One v None 0.2337 1.263 1.103 1.447 26 
Primary Care Provider Multiple v None -0.2207 0.802 0.647 0.992 -24 
Major ADG (vs none)      
1 -0.2991 0.741 0.603 0.911 -33 
2 -0.3119 0.732 0.588 0.911 -34 
3 -0.3969 0.672 0.532 0.849 -44 
4 -0.4074 0.665 0.522 0.848 -45 
Chronic Conditions (vs none)      
1 0.0740 1.077 0.816 1.422 8 
2 -0.1606 0.852 0.645 1.125 -18 
3 -0.0034 0.997 0.749 1.327 0 
4 -0.1513 0.860 0.637 1.159 -17 
5 -0.3968 0.672 0.489 0.924 -44 
  6+ -0.3630 0.696 0.505 0.958 -40 
Frailty 0.2170 1.242 1.090 1.415 24 
Referral 0.9739 2.648 2.170 3.252 107 
Generic drug count -0.0176 0.983 0.973 0.992 -2 
Condition      
  Asthma -0.134 0.875 0.77 0.993 -15 
  Rheumatoid Arthritis -0.4847 0.616 0.455 0.824 -53 
  Congestive Heart Failure -0.0247 0.976 0.82 1.159 -3 
  Depression -0.1350 0.874 0.769 0.992 -15 
  Diabetes -0.0670 0.935 0.822 1.064 -7 
  Disorders of Lipid Metabolism -0.0330 0.968 0.84 1.114 -4 
  Hypertension 0.1607 1.174 1.015 1.36 18 
  Ischemic Heart Disease 0.1734 1.189 0.986 1.433 19 
Outcome: Patient Enrolled in Case Management program following screening 
95% CL: 95% Confidence interval for Odds ratio 





5.2.3 Medicaid Plan Model, Validated on Employee and US Family Health plans 
An alternative method to the split-half validation approach was also created to derive and 
validate a model. This approach used the Medicaid data to derive a set of coefficients, which was 
then validated against the Employee and US Family Health plan data. Modifications using the 
Employee and US Family Health plan data were also tried but these yielded similar or poorer 
results than the Medicaid plan model. Applying the Medicaid model to the Employee plan data 
resulted in a high C-Statistic of 0.6410, which was almost the same C-Statistic as the originating 
model (0.6423) for the initial model. The US Family Health plan showed a much lower C-
Statistics of 0.5443 which would indicate this model was of less significance, with a result close 
to 0.5 (a C-Statistic associated with random chance). The final model improved on these results 
with C-Statistics of 0.6410 on the Employee plan data and 0.5443 on the US Family Health plan 
data. The poor validation result for the US Family Health plan suggests that this model is less 
generalizable than the split-half model. 
 
Table 5-10 Medicaid Plan model, Validated on Employee and US Family Health plans 
   Model C-Statistic 
 Population / Plan N Outcome Model 0 Model1 Model7 
Medicaid Plan (Training) 6478 0.4248 0.5846 0.6423 0.6654 
Employee Plan (Validation) 2836 0.3829 0.5721 0.6410 0.6432 
DoD Plan (Validation) 2050 0.3590 0.5244 0.5443 0.5821 
Outcome: Patient Enrolled in Case Management program following screening 
Model 0 independent variables: Gender, Age 
Model 1 independent variables: Gender, Age, Major ADG count, Referral, Plan Enrollment ≥ 
6 months, Plan Enrollment ≥ 12 months 
Model 7 independent variables:  Gender, Age, Primary Care Provider, Major ADG count 




5.3 Factor Analysis approaches using additional patient recorded data 
A factor analysis was undertaken with the SAS application (SAS Institute Inc, 2010) to review 
the selected items, using the approach utilized by Bower and Colleagues (Bower et al., 2002). 
This approach assumes that are there are unmeasured latent variables (factors) that underlie the 
observed variables. This method was utilized in order to explore the reduction of input variables 
to a measure, to inform the theoretical framework, and assess the construct validity of a measure 
derived from the observed variables. 
 
A logistic regression was undertaken on the care management records for the cohort of members 
who completed Personal Wellness Profile (PWP) surveys and were screened for high or 
moderate care management. An initial model of participation in care management was formed 
using selected PWP variables plus age and ADGs. The PWP variables used were: general health 
perception, social support, last physical exam, preventive exams, and readiness to change. 
 
A score was also created for each of the input variables using the points method described by 
Sullivan and Colleagues (Sullivan et al., 2004), originally developed of the Framingham Heart 
Study data. This tool was developed to aid calculation and decision making by clinicians. 
 
5.3.1 Factor Analysis Updated Model using Personal Wellness Profile Data 
Personal Wellness Profile data was available for those patients in the Employer plan who had 
carried out the survey (see appendix 8.2). Survey results were linked using the patient study 
identifier, for the survey that was completed prior to the first care management screening 
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outcome. This led to a sample of 876 patients (30.9%). Descriptive analyses were produced, 
followed by an exploratory factor analysis, and a further logistic regression model was produced 
to predict participation in a care management program using the additional PWP variables. 
 
5.3.2 Personal Wellness Profile Factor Analysis: Adding patient engagement to predict 
CM enrollment 
Table 5-11 shows the descriptive statistics for the Personal Wellness Profile (PWP) survey 
responses compared to the commercial Employee Health plan. The 877 PWP Survey responses, 
with an outcome, represented a 30.9% sample of all initial case management records (2836 total 
case management records with an associated outcome). The proportion of patients who enrolled 
for care management was higher for those who completed the survey than for the underlying 
population (45.2% compared to 38.3%). Those who completed the survey also had a lower level 
of chronic conditions and multimorbidity (as measured by the number of Major Aggregated 




Table 5-11: Employee Health Plan Descriptive Statistics, PWP Survey 







N 1750 1086 481 396 
 61.7% 38.3% 54.8% 45.2% 
Female 62.1% 66.3% 84.8% 84.1% 
Age at Screening 51.18 48.32 48.91 46.30 
Plan Enrollment (days) 672.87 664.59 708.63 682.62 
Chronic Conditions 3.66 3.01 3.41 2.45 
Major ADGs 1.80 1.35 1.63 0.97 
PWP survey total n = 876 
 
Table 5-12 shows the results of the factor analysis. Factors with a weighting in excess of 0.4 are 
highlighted to illustrated potentially correlated or grouped variables. This analysis identified five 
factors that appear correlated with multiple variables:  
 readiness to change: exercise, nutrition, and weight; 
 multimorbidity and unique provider relationship; 
 readiness to change: smoking, alcohol consumption; 
 preventative examinations and enrolment in the health plan; 
 general health perception, support and last physical exam. 
These factors appear consistent with the original reasons for selection of the items. The item 
readiness to change: handle stress well appears correlated to two factors, which may indicate 




Table 5-12: Factor Analysis of selected variables: Rotated Factor Pattern 
Item Factor1 Factor2 Factor3 Factor4 Factor5 
Major ADG -0.03784 0.80546 0.02276 -0.06384 -0.02274 
Chronic Conditions -0.01702 0.80604 -0.06898 0.03881 0.05311 
Unique provider 0.02112 0.67921 0.03388 0.15433 -0.02657 
Plan Enrollment 12 months -0.14502 -0.03675 0.14310 0.49052 -0.21448 
General Health Perception -0.23783 0.22995 0.07274 -0.09452 0.59948 
Social Support 0.14961 -0.02766 -0.02708 0.21984 0.64757 
Last Physical Exam 0.06371 -0.10964 0.02451 -0.11776 0.58608 
Preventive Bowel 0.06284 0.14467 -0.03019 0.63950 -0.05216 
Preventive Dental 0.27059 0.01398 -0.08623 0.57094 0.02822 
Preventive Flu 0.10991 -0.00445 0.13038 0.57039 0.31122 
Change Exercise 0.81404 -0.04596 -0.03418 0.08250 -0.04507 
Change Nutrition 0.83672 0.02472 0.07297 0.06096 0.0451 
Change Weight 0.81146 0.01346 0.08541 0.06158 0.04195 
Change Stress 0.63015 -0.03525 0.46018 -0.00054 0.02421 
Change Smoke 0.35077 0.01736 0.81949 0.08028 0.04060 
Change Alcohol 0.35346 -0.01427 0.83624 0.05929 0.04566 
Change Overall 0.78659 -0.00588 0.21281 0.02137 0.01152 
* Factor loading in bold where > 0.4 
 
The variables identified by the factor analysis were added to a logistic regression model on the 
outcome of case management participation.   
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Table 5-13 shows the resulting odds ratios, confidence intervals, and derived score for each 
variable. The scores were derived from the estimates using the points method described by 
Sullivan and Colleagues (Sullivan et al., 2004), originally developed from the Framingham Heart 
Study data. This tool was developed to aid calculation and decision making by clinicians. Each 
of the individual estimates was divided by the base weight (chosen to be 0.1720, the absolute 
value of the smallest estimate, Age 35-44) and then rounded to the nearest integer. These scores 
were shared with clinical colleagues for review without adjustment. The scores appear to be 
generally internally consistent, i.e. these progressively increase or decrease for ordinal variables. 
Positive scores indicated variable values that are associated with increased likelihood of 
participation in care management (i.e. enrolment in a care management program), while negative 
scores are associated with the decreased probability of a member enrolling. 
 
The major ADG counts are significant for all values, and show odds ratios less than one, i.e. 
members with Major ADGs are less likely to participate than those without. The odds ratios 
reduce for counts of major ADGs 2, 3 and 4+ indicating that with increase morbidity members 
are less likely to participate. Most other variables are not statistically significant (indicated by 
confidence intervals that include values lower and higher than 1.0), but some individual values 
are significant such as age 65-69, last physical exam within one year, readiness to change stress 
within one month. Age 65-69 has a significant odds ratio of 0.278, indicating a 71% lower rate of 
participation (adjusting for other factors) than for 45-49 year old members. For members with 
last physical exam within one year the odds ratio was 6.589. This model produced a C-Statistic 




Table 5-13: CM Participation Likelihood (CMPL) Score: Based on PWP engagement 
response and other variables 






   
Male 
 






20-24 -0.4063 0.666 (0.209-2.209) -2  
25-29 -0.6233 0.536 (0.257-1.111) -4  
30-34 -0.4159 0.660 (0.337-1.286) -2  





50-54 -0.5869 0.556 (0.328-0.937) -3  
55-59 -0.6702 0.512 (0.29-0.898) -4  
60-64 -0.4630 0.629 (0.346-1.139) -3  
65-69 -1.1534 0.316 (0.118-0.782) -7  






1 -0.6851 0.504 (0.334-0.757) -4  
2 -0.9108 0.402 (0.246-0.653) -5  
3 -1.3535 0.258 (0.136-0.478) -8  
4+ -1.5487 0.213 (0.098-0.44) -9 
Chronic Conditions   
 
  
1 -0.1402 0.869 (0.488-1.541) -1  
2 -0.6319 0.532 (0.295-0.949) -4  
3 -0.5065 0.603 (0.32-1.126) -3  
4 -0.5363 0.585 (0.303-1.12) -3  
5 -1.0660 0.344 (0.162-0.718) -6  






Y 0.3228 1.381 (0.933-2.046) 2 




excellent -1.0912 0.336 (0.052-1.782) -6  
very good -0.9293 0.395 (0.064-1.992) -5  
good -0.7703 0.463 (0.076-2.314) -4  
fair -1.0804 0.339 (0.055-1.735) -6  






Yes 0.6279 1.874 (0.674-5.566) 4  
No 1.0085 2.742 (0.779-10.137) 6 
 
77 










1 year 0.1242 1.132 (0.221-6.698) 1  
2 year -0.3231 0.724 (0.13-4.596) -2  
3 year 0.3692 1.447 (0.117-18.569) 2  
4 year 0.5392 1.715 (0.054-32.052) 3  
5+ year -1.8496 0.157 (0.012-1.763) -11 










no interest 1.5160 4.554 (0.738-33.708) 9  
next 6 months 1.0865 2.964 (0.528-20.248) 6  
this month 1.1010 3.007 (0.52-21.162) 6  
recently started 1.5756 4.834 (0.85-33.581) 9  





no interest -2.4953 0.082 (0.009-0.651) -15  
next 6 months -1.8356 0.160 (0.02-1.077) -11  
this month -1.5336 0.216 (0.029-1.339) -9  
recently started -1.8956 0.150 (0.02-0.947) -11  






no interest 0.3507 1.420 (0.613-3.327) 2  
next 6 months 0.3395 1.404 (0.556-3.587) 2  
this month 0.6864 1.986 (0.625-6.435) 4  
recently started 0.7481 2.113 (0.752-6.063) 4  






no interest 1.9378 6.943 (1.545-35.751) 11  
next 6 months 1.6536 5.226 (1.365-23.465) 10  
this month 1.2858 3.618 (0.951-16.154) 7  
recently started 1.4572 4.294 (1.151-18.966) 8  






no interest 0.7526 2.123 (0.703-6.541) 4  
next 6 months -0.0532 0.948 (0.317-2.859) 0  
this month 0.9537 2.595 (0.918-7.51) 6  
recently started 0.1970 1.218 (0.452-3.354) 1  






no interest -0.4891 0.613 (0.255-1.457) -3 
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next 6 months 0.0257 1.026 (0.29-3.607) 0  
this month -0.9616 0.382 (0.09-1.547) -6  
recently started -0.4223 0.656 (0.234-1.79) -2  







no interest -1.5137 0.220 (0.054-0.857) -9  
next 6 months -1.4392 0.237 (0.071-0.745) -8  
this month -0.8580 0.424 (0.128-1.337) -5  
recently started -1.2898 0.275 (0.085-0.848) -7  
already doing this -0.8378 0.433 (0.138-1.283) -5 
Mean rate of enrolment 45.2%, Base pr Female 45-49 = 0.8346 
Intercept 1.3554, Score Base weight 0.1720 
Probability calculation = Exp(1.3554 + 0.172.∑score) / 1 + Exp(1.3554 + 0.172.∑score)  
ROC AUC = 0.7332 
CI: Odds Ratio 95% confidence interval 
 
The model produced a C-Statistic of 0.7332. At a probability level of 0.4 the sensitivity was 
66.4%, sensitivity 54.5%, and the positive predictive values was 54.6%. An individual’s 
probability is calculated by summing the scores and substituting in to the following equation: 
𝑃𝑒𝑛𝑟𝑜𝑙𝑙 =
𝑒1.3554 + 0.172×∑𝑠𝑐𝑜𝑟𝑒
1 + 𝑒1.3554 + 0.172×∑𝑠𝑐𝑜𝑟𝑒
 
For example, an individual aged 55 (score -4), with 1 ADG (-4), 1 chronic condition (-1), poor 
general health perception (2), no social support (6), and no other responses, would have a total 
score of -1, and a resulting probability of 0.77. 
𝑃𝑒𝑛𝑟𝑜𝑙𝑙 =
𝑒1.3554 + 0.172×−1








If the same patient had 4 ADGs (-9), and 6 Chronic Conditions (-4) they would have a total score 




Figure 5-5 shows a box and whisker diagram of the distribution of probabilities from the initial 
application of the CM Participation Likelihood (CMPL) scores to the data, for those who did not 
enroll in the CM program (left hand distribution) and those who did enroll (right hand 
distribution). The non-enrollees had a mean probability of 0.3795, and the enrollees 0.5379.  
 








5.3.3 Principal Component Cluster Analysis 
Variable Cluster Analysis using the SAS Procedure VarClus (Liau et al., 2011) was applied to 
the variables presented by the factor analysis to create hierarchical clusters of the variable values. 
This approach helped to understand the subsets of values within each variable, reducing the 
number of categories for consideration, with the potential for creating aggregate categories for 
use in sub-population analysis. An iterative approach of combining variable values from the 
cluster analysis led to five clusters, based on duration of patients in care management programs, 
plan enrolment, age, and numbers of Major ADGs and chronic diagnoses. Table 5-14 shows the 
results of the cluster analysis and the R-Squared value for each of the variables within its own 
cluster, the R-Squared values for the next nearest cluster, with the final column showing the ratio 
of inverse R-Squared values (1- R2) where low ratio values are indicative of good clustering. 
Table 5-14: Results of Cluster Analysis 
5 Clusters R-squared with 1-R2 





Cluster 1 CM > 3 months 0.6961 0.023
2 
0.3112 
 CM > 6 months 0.8435 0.029
5 
0.1613 
 CM > 12 months 0.6454 0.023
5 
0.3632 
Cluster 2 Plan Enrollment > 12 months 0.7811 0.009
5 
0.2210 
 Plan Enrollment > 6 months 0.7811 0.064
0 
0.2338 
Cluster 3 0-2 Major ADG 0.0144 0.001
9 
0.9874 
 Age 18 - 34 0.8805 0.072
1 
0.1287 
 Age 35 - 64 0.8775 0.024
0 
0.1256 
Cluster 4 6 Major ADG 0.2039 0.002
6 
0.7981 
 0-1 Chronic Conditions 0.5085 0.067
0 
0.5267 
 Unique Providers 0.4839 0.029
4 
0.5317 
 Age 65+ 0.2018 0.026
4 
0.8198 
Cluster 5 3-4 Major ADG 0.5462 0.012
0 
0.4593 






The clinical variables identified by the exploratory factor and cluster analyses were combined to 
form four morbidity complexity groups, and sub-population analysis using these groups and 
other options were discussed with JHHC colleagues. These groups were used to investigate 
further the within-population differences in cost and utilization outcomes in section 0. These four 
groups were patients with: 
 less than two chronic conditions; 
 two or more chronic conditions with less than three Major Aggregated Diagnoses 
Groups; 
 three or four Major Aggregated Diagnoses Groups; 





5.4 Cost and Utilization Outcomes, Year 2 
The costs and utilization measures 12 months following first screening (for care management) 
were compared across the three health plans, for those who did and did not enroll in a care 
management program. 
 
These results are divided between two sub-sections, section 5.4.1 showing the overall (crude) 
results, and section 5.4.2 showing the results of applying propensity scoring methods. The 
Propensity Scoring Methods were applied to reduce the effects of selection bias and provide a 
comparison of outcomes based on matched pairs of those not enrolled in care management and 
those enrolled (“control” and “treatment” cases). 
 
5.4.1 Cost and Utilization Outcomes, Year 2: Initial results 
The tables below show a comparison of the unadjusted mean total cost, number of 
hospitalizations, and emergency visits per patient for the year following first screening, for those 
who did and did not enroll in a care management program. The Employee health plan showed an 
increased cost for patients who did not enroll in care management of $3,312 (23,315 - 20,003, 
+14.2%), while the mean number of hospitalizations and emergency visits were similar between 




Table 5-15 Employee Health Plan (EHP): Year 2 Outcome Measures, Care Management 
Enrollment (unadjusted) 
  All Data (n=2365)   
Measure Not-Enrolled (n=1442) Enrolled (n=923) P value 
 Mean CI Mean CI   
Total Cost $ 23,315 (20966-25664) 20,003 (17058-22948) 0.085  
Inpatient hospitalizations 0.3454 (0.299-0.391) 0.3315 (0.276-0.387) 0.707  
Emergency Visits 0.5902 (0.519-0.661) 0.5959 (0.502-0.69) 0.924  
 
The results for the Medicaid plan also showed an increased cost for patients who did not enroll in 
care management of $2728 (29,373 - 26,644, +9.3%); this cost increase was statistically 
significant. The higher rates of inpatient hospitalizations (1.02 compared to 0.83) and emergency 
visits (3.13 compared to 2.63) were also statistically significantly lower. 
 
Table 5-16 Medicaid Health Plan: Year 2 Outcome Measures, Care Management 
Enrollment (unadjusted) 
  All Data (n=5266)   
Measure Not-Enrolled (n=2935) Enrolled (n=2331) P value 
 Mean CI Mean CI   
Total Cost $ 29,373 (27819-30926) 26,644 (24809-28479) 0.026 * 
Inpatient hospitalizations 1.0273 (0.956-1.098) 0.8280 (0.751-0.905) 0.000 * 
Emergency Visits 3.1322 (2.94-3.324) 2.6319 (2.461-2.803) 0.000 * 
 
The Family Health plan in contrast to the results above, showed a decrease for patients who did 
not enroll in care management of $1724 (29,432-31,156, -5.9%), but the confidence intervals 
showed that this difference was not significant. The inpatient hospitalization rates were similar 
but the emergency visit rate was significantly lower for patients who did enroll in care 





Table 5-17 Family Health Plan: Year 2 Outcome Measures, Care Management Enrollment 
(unadjusted) 
  All Data (n=1703)   
Measure Not-Enrolled (n=1122) Enrolled (n=581) P value 
 Mean CI Mean CI   
Total Cost $ 29,432 (26900-31964) 31,156 (27265-35047) 0.466  
Inpatient hospitalizations 0.6078 (0.536-0.680) 0.6489 (0.562-0.736) 0.477  
Emergency Visits 0.7665 (0.671-0.862) 0.9862 (0.802-1.171) 0.038 * 
 
To gain a greater understanding of the sub-populations of patients the groups derived from the 
cluster analysis were applied to the analysis. 
 
 
Table 5-18 shows the outcome analysis for the 4 groups suggested by exploratory factor and 
cluster analysis. The first group includes all members with less than 2 chronic conditions. The 
other three groups include all members with 2 or more chronic conditions, and increasing 
number of Aggregated Diagnoses Groups (ADGs), such that the most complex group consists of 
members with 5 or more ADGs. A comparison of claims costs in the second year within each of 
these complexity groups, was made between: those who enrolled in care management, and those 
who did not enroll. The cost ratio is the Year 2 mean cost for those enrolled in a care 




Table 5-18 Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by 
Count of Chronic Conditions and Major ADGs 
Plan/Participation N Mean (95% CI)   N Mean (95% CI) Diff P value 
  Not Enrolled   CM Enrolled   
Employee Health Plan      
   
 <2 Chronic Conditions 267 12,463 (9538-15387) 
 268 10,579 (8508-12649) 1,884 0.3012 
 0-2 Major ADGs 801 20,585 (17509-23660) 
 489 18,433 (15807-21058) 2,152 0.2962 
 3-4 Major ADGs 306 35,012 (28735-41289) 
 129 31,008 (20625-41390) 4,004 0.5147 
 5+ Major ADGs 68 45,453 (32664-58241) 
 37 70,643 (20288-120998) -25,190 0.3282 
Medicaid Health Plan         
 <2 Chronic Conditions 367 15,104 (12193-18015) 
 559 13,305 (11352-15256) 1,800 0.3131 
 0-2 Major ADGs 921 22,844 (20399-25288) 
 828 20,688 (18285-23090) 2,156 0.2172 
 3-4 Major ADGs 1108 32,328 (29808-34846) 
 674 33,614 (29927-37301) -1,287 0.5717 
 5+ Major ADGs 539 44,168 (39650-48684) 
 270 55,127 (46356-63898) -10,959 0.0291 
Family Health Plan          
 <2 Chronic Conditions 42 21,592 (4786-38397) 
 32 16,694 (11001-22386) 4,898 0.5786 
 0-2 Major ADGs 499 23,318 (20388-26247) 
 244 23,911 (18964-28858) -593 0.8391 
 3-4 Major ADGs 444 32,979 (28747-37209) 
 218 36,014 (28062-43965) -3,035 0.5071 
 5+ Major ADGs 137 42,607 (32774-52440) 
 87 44,621 (36311-52930) -2,013 0.7569 
CI, Confidence Interval, CM, Care Management, Diff, Difference = Not Enrolled mean – CM Enrolled mean 
Excludes patients with zero year 2 costs 
 
The Medicaid plan had lower year 2 costs for those who enrolled for the two least complex 
groups of member, but the costs were higher amongst those enrolled for the two complex groups. 
For the employee plan those who enrolled had lower costs for all but the most complex group. 
The Family health plan general produced higher costs for those who enrolled, except for the least 
complex group. While Table 5-15 and Table 5-16 showed that the overall costs for those who 
enroll are generally lower in year 2 than for those who do not enroll. Creating a breakdown by 
complexity suggests that as the complexity increases, care management enrolment increases 
claims costs over those who are not enrolled. The reduced costs are for those who are less 




5.4.2 Cost and Utilization Outcomes, year 2: Propensity Score Matching 
To better adjust for potential bias when assessing the impact of CM enrollment, Propensity Score 
Matching (PSM) was carried out separately for each of the three plans, first using Nearest 
Neighbor (NN) matching and then using the Caliper method. In the NN method for each 
treatment case the control is chosen that had the closest propensity score (probability of 
enrollment in case management). This method ensures a control match for each treatment case, 
but does not ensure that the absolute difference in scores are close. The Caliper method allows 
for a minimum absolute difference in prevalence to be specified, but does result in data loss 
where a match cannot be found within the specified absolute difference (Coca-Perraillon, 2006). 
 
The mean prevalence scores (probability of care management enrollment) for two Propensity 
Score Matching (PSM) methods are show in Table 5-19. The expectation of a successful 
matching algorithm would produce non-enrolled and enrolled groups with similar risks of care 
management enrolment. The mean prevalence scores for the Near Neighbor method were 
statistically significantly different for the Employee Health plan (0.4487, 0.4582) and the 
Medicaid Health Plan (0.4325, 0.4602) with t-test probabilities of less than 0.05 (P Values 0.080, 
0.000 respectively), while the scores were close for the Family Health Plan (0.3576, 0.3578). The 
results of the Caliper method were closer by design, and not statistically significant for any of the 
three plans, but this approach also leads to loss of data where ‘close’ matches are not found in 
the data. Across the three plans the data loss of enrolled cases without matches was: Employee 
Health 6.28%, Medicaid Health Plan 13.21%, and Family Health Plan 1.20%. 
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Table 5-19 Mean Prevalence (probability of CM Enrollment) for two Propensity Score matching (PSM) methods 
 PSM - Near Neighbor  PSM - Caliper (0.01) 
 Not-Enrolled Enrolled   Not-Enrolled Enrolled  
 n mean CI n mean CI P value  n mean CI n mean CI P value 
                
Employee Health 923 0.4487 (0.441-0.456) 923 0.4582 (0.450-0.466) 0.080  865 0.4468 (0.439-0.455) 865 0.4469 (0.439-0.455) 0.993 
                
Medicaid Health Plan 2331 0.4325 (0.429-0.436) 2331 0.4602 (0.456-0.465) 0.000  2023 0.4364 (0.432-0.441) 2023 0.4365 (0.432-0.441) 0.973 
                
Family Health Plan 581 0.3576 (0.350-0.365) 581 0.3578 (0.350-0.365) 0.972  574 0.3546 (0.347-0.362) 574 0.3546 (0.348-0.362) 0.995 
                
Caliper method, % Data Loss of enrolled cases without matches: 





Analysis of Year 2 Outcomes – Matched pairs 
The mean annual costs, inpatient hospitalization and emergency visit rates in the 2nd year, 
following screening for Care Management for each of the health plans results (using the two 
matching methods) are in Table 5-20. The table shows the potential overall savings for each plan 
that the ‘treatment group’ (Enrollment in CM) showed compared to the ‘control group’ (Not 
enrolled). 
 
The Employee plan showed cost reductions of $4486.86 (18.3%) using Near Neighbor matching 
and 4186.91 (17.1%) for Caliper matching, which were higher than the non-matched results in 
the previous section.  The inpatient hospitalization and emergency visit rates were also reduced. 
The Medicaid plan showed a reduction of costs of $4074.07 (13.3%) and $1372.66 (4.6%), again 
with reduced hospitalization and emergency visit rates. The Family Health plan also showed cost 
reductions for those enrolled in care management of $2458.51 (7.3%) and $2604.29 (7.7%), 
which contrasts with the result in the previous section before matching was applied (costing 





Table 5-20 Employee Health Plan: Propensity Score matching, Year 2 Outcome Measures, Care Management Enrollment 
Plan / Measure mean CI mean CI P value*  mean CI mean CI P value* 
 Not-Enrolled Enrolled   Not-Enrolled Enrolled  
  PSM - Near Neighbor (n=1846)  PSM - Caliper (n=1730) 
 (n=923) (n=923)   (n=865) (n=865)  
Employee Health       
Total Cost $ 24,490 (21299-27680) 20,003 (17058-22948) 0.043  24,449 (21084-27814) 20,262 (17134-23390) 0.074 
Inpatient hospitalizations 0.3499 (0.292-0.408) 0.3315 (0.276-0.387) 0.654  0.3387 (0.279-0.399) 0.3329 (0.275-0.391) 0.892 
Emergency Visits 0.6652 (0.565-0.765) 0.5959 (0.502-0.69) 0.322  0.6763 (0.571-0.782) 0.5977 (0.498-0.697) 0.287 
Measure Not-Enrolled Enrolled   Not-Enrolled Enrolled  
  PSM - Near Neighbor (n=4662)  PSM - Caliper (n=4046) 
 (n=2331) (n=2331) P value* (n=2023) (n=2023)  
Medicaid Health Plan            
Total Cost $ 30,718 (28906-32531) 26,644 (24809-28479) 0.002  29,727 (27841-31613) 28,354 (26306-30403) 0.334 
Inpatient hospitalization 1.0854 (1.003-1.167) 0.828 (0.751-0.905) 0.000  1.0400 (0.953-1.127) 0.8883 (0.802-0.974) 0.015 
Emergency Visits 3.2986 (3.071-3.526) 2.6319 (2.461-2.803) 0.000  3.2012 (2.963-3.439) 2.695 (2.505-2.885) 0.001 
Measure Not-Enrolled Enrolled   Not-Enrolled Enrolled  
  PSM - Near Neighbor (n=1162)  PSM - Caliper (n=1148) 
 (n=581) (n=581) P value* (n=574) (n=574) P value* 
Family Health Plan            
Total Cost $ 33,614 (29786-37443) 31,156 (27265-35047) 0.377  33,920 (30052-37788) 31,316 (27382-35251) 0.354 
Inpatient hospitalization 0.6936 (0.595-0.793) 0.6489 (0.562-0.736) 0.505  0.6986 (0.599-0.799) 0.6516 (0.564-0.740) 0.488 
Emergency Visits 0.8985 (0.745-1.052) 0.9862 (0.802-1.171) 0.473  0.9007 (0.745-1.056) 0.9895 (0.803-1.176) 0.472 
Caliper method, % Data Loss of enrolled cases without matches: 




Analysis of Year 2 Outcomes – Matched pairs by plan and sub group 
The analysis of mean total cost by plan and by sub group is shown in Table 5-21. For all of the 
plans, and all sub groups except the highest complexity group (5+ Major ADGs) there are lower 
costs for the enrolled populations. The reductions in costs for the enrolled populations are 
consistently lower for both of the matched pairs methods. In contrast, enrolled patients in high 
complexity sub-groups showed a reduction compared with the all data (crude) results. 
 
The EHP population using the PSM methods produced apparent cost savings across the three less 
complex sub-groups for those who enrolled in case management. The least complex group of 
patients with less than 2 chronic conditions showed reduced costs using the Nearest Neighbor 
method of $3484.61 ($10,579 for enrollees compared to 14,064 for non-enrollees, 24.8%), and 
$2395.36 ($10,952 - $13,347, 18.9%) using the Caliper method. The sub-group of patients with 0 
to 2 Major ADGs and 2 or more chronic conditions showed cost reductions of $4192.58 (18.5%) 
and $4489.28 (20.0%) for the two PSM methods respectively. The third sub-group of patients 
with 3 or 4 Major ADGs also showed a mean cost reduction of $8350.29 (21.2%) and $8315.93 
(21.1%). The highest complexity sub-group, of patient with 5 or more Major ADGs, was the 
only group that showed a cost increase for those enrolled in case management compared to those 
who were not enrolled; a mean increase of $21,898.95 (44.9%) and $18,463.00 (35.4%) using 
the Nearest Neighbor and Caliper methods respectively. 
 
The Medicaid plan population showed similar results to the EHP population with the 3 least 
complex sub-groups showing costs savings for the enrolled population, with only the highest 
complexity sub-group showing an increase in cost for those enrolled in care management 
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compared to those who were not enrolled. The least complex group of patients with less than 2 
Chronic Conditions showed reduced costs using the Nearest Neighbor method of $1634.77 
(13,305-14,939, 10.9%) compared to $1480.85 (13,737-15,218, 9.7%) using the Caliper method. 
The sub-group of patients with 0 to 2 Major ADGs and 2 or more chronic conditions showed 
cost reductions of $4019.44 (16.3%) and $3468.01 (14.1%) for the two PSM methods 
respectively. The third sub-group of patients with 3 or 4 Major ADGs also showed a mean cost 
reduction of $1017.33 (2.9%) and 1274.02 (13.7%). The highest complexity sub-group, of 
patients with 5 or more Major ADGs, was the only group that showed a cost increase for case 
management enrollees compared to non-enrollees, a mean increase of $8348.21 (17.8%) and 
$11,288.15 (25.7%) using the Nearest Neighbor and Caliper methods respectively. 
 
The USFHP population showed similar results to the other two populations, with only the most 
complex sub-group showing a cost increase for those enrolled in case management. The least 
complex group of patients with less than 2 chronic conditions showed reduced costs using the 
Nearest Neighbor method of $5902.42 (26.1%) and $10,070.68 (27.4%) using the Caliper 
method, but the lower number of patients in this group may underlie the large difference between 
the two methods. The sub-group of patients with 0 to 2 Major ADGs and 2 or more chronic 
conditions showed cost reductions of $4848.17 (16.9%) and $4861.80 (16.8%) for the two PSM 
methods respectively. The third sub-group of patients with 3 or 4 Major ADGs also showed a 
mean cost reduction of $1727.65 (4.6%) and $1727.65 (4.6%). The highest complexity sub-
group, of patients with 5 or more Major ADGs, was the only group that showed a cost increase 
for those enrolled in case management compared to those who were not; a mean increase of 
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$1451.33 (3.4%) higher and $1451.33 (3.4%) using the Nearest Neighbor and Caliper methods 
respectively. 
 
This chapter described the study populations, the results of the investigation of factors that 
underlie participation in the care management programs, the derivation and application of 
models to predict participation, and the measurement of patients’ outcomes following 
participation or non-participation in care management. 
 
The following chapter discusses these results, draws conclusions including potential implications 
for care management, and outlines the limitations of the study.  
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Plan/Sub-Group N Total Cost (CI) N Total Cost (CI) P value* N Total Cost (CI) N Total Cost (CI) P value* 
 Not-Enrolled Enrolled   Not-Enrolled Enrolled  
 
 PSM - Near Neighbor (n=1846)  PSM - Caliper (n=1730) 
 
Employee Health                
 
<2 Chronic Conditions 207 14,064 (10354-17774) 268 10,579 (8508-12650) 0.107  194 13,347 (9653-17042) 237 10,952 (8634-13270) 0.279 
 
0-2 Major ADGs 528 22,625 (18404-26847) 489 18,433 (15807-21058) 0.098  491 22,492 (18000-26984) 462 18,003 (15264-20741) 0.094 
 
3-4 Major ADGs 151 39,359 (29010-49707) 129 31,008 (20626-41391) 0.261  146 39,324 (28665-49983) 129 31,008 (20626-41391) 0.270 
 
5+ Major ADGs 37 48,744 (30074-67415) 37 70,643 (20288-120998) 0.411  34 52,180 (32275-72085) 37 70,643 (20288-120998) 0.491 
 
  PSM - Near Neighbor (n=4662)  PSM - Caliper (n=4046) 
 
Medicaid Health Plan                
 
<2 Chronic Conditions 342 14,939 (11901-17978) 559 13,305 (11353-15257) 0.374  316 15,218 (11978-18458) 382 13,737 (11476-15998) 0.461 
 
0-2 Major ADGs 751 24,708 (21778-27638) 828 20,688 (18286-23091) 0.037  689 24,541 (21440-27642) 703 21,073 (18416-23731) 0.096 
 
3-4 Major ADGs 821 34,632 (31606-37658) 674 33,614 (29927-37302) 0.675  689 34,829 (31522-38135) 668 33,555 (29842-37267) 0.615 
 
5+ Major ADGs 417 46,779 (41448-52110) 270 55,127 (46356-63899) 0.110  329 43,839 (38418-49260) 270 55,127 (46356-63899) 0.032 
 
 PSM - Near Neighbor (n=1162)  PSM - Caliper (n=1148) 
 
Family Health Plan                 
<2 Chronic Conditions 24 22,597 (-5237-50430) 32 16,694 (11002-22387) 0.669  19 26,907 (-8685-62499) 30 16,836 (10872-22800) 0.561 
 
0-2 Major ADGs 270 28,759 (23871-33647) 244 23,911 (18964-28858) 0.170  268 28,867 (23946-33789) 239 24,005 (18965-29046) 0.175 
 
3-4 Major ADGs 215 37,742 (31538-43945) 218 36,014 (28062-43966) 0.736  215 37,742 (31538-43945) 218 36,014 (28062-43966) 0.736 
 




6 DISCUSSION AND CONCLUSIONS 
This chapter discusses the study’s findings in a broader context. It will provide an overview and 




This study provides an exploration of participation (specifically enrollment) in care management 
plans using routine claims data and additional care management administrative data, by applying 
single and multilevel logistic regression techniques. Consistent with its four main aims this 
study: 1) developed an approach for defining and measuring the achievement of patient 
participation in the care management context; 2) applied a definition of participation to three 
different populations screened for care management, to determine which individual and 
organizational factors were associated with patients’ participation; 3) developed models to 
predict participation; and 4) created an analytic approach for the measurement of care 
management participation across the study populations to enhance understanding of patient 
groups and sub-populations. 
 
Specifically, the results identified patient factors associated with propensity to participate, further 
developed models to predict future participation, and further developed analytics to assist in 




6.2 Summary and Interpretation of Findings 
6.2.1 Measuring patient participation 
This study derived an operational definition of patient participation from routine administrative 
data. Specifically, patients who had been screened for care management, and then consented to 
enroll into a program or declined to be enrolled. This measure was achieved by linking a care 
management administrative database to claims data. This measure benefits from being simple to 
apply using routine data, and can reasonably be assumed to be consistent with self-efficacy and 
the evidence linking initiating change to continuing behavioral change, i.e. assuming that 
enrolling or initiating care management will lead to participation (Rimer, 2008). 
 
Duration in a care management program was also analyzed, but following review with clinical 
and administrative colleagues, the precise reason for discontinuing enrollment could not be 
distinguished, so the measure was not fully developed as a dependent variable. In the future it 
would be useful to record the type of care management intervention, whether the patient or the 
plan had dis-enrolled, and the extent to which the intervention had been completed. 
 
6.2.2 Factors Associated with Care Management participation 
The initial exploratory models included a number of individual level factors associated with a 
patient’s likelihood to enroll or not to enroll in a case management program. Patients with higher 
multimorbidity, and older patients, holding other effects the same, were associated with a 
decreased propensity to enroll in care management programs. Table 6-1 shows the odds ratios 
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decreasing as the number of chronic diseases increases for the Medicaid and Employee Health 
plans, and the odds ratios also decreasing as the number of Major ADGs increases. 
 
Table 6-1 Patient factors with reduced likelihood of member’s acceptance to join CM 
program: Three Health Plans 
 Odds Ratio Estimates 
Variable 
Medicaid 
(n = 6029) 
Employee 
(n = 2692) 
US Family 
(n = 2028) 
Age 35-64 (base 18-34) 0.761* 0.984 0.980 
Age 64+  n/a 0.525* 0.914 
Primary Care Provider Multiple vs 1 0.605* 0.434*  n/a 
Chronic Conditions (vs none)    
1 0.735* 0.837 1.378 
2 0.696* 0.642* 1.364 
3 0.654* 0.746 1.891 
4 0.641* 0.513* 1.591 
5 0.599* 0.447* 1.415 
  6+ 0.474* 0.407* 1.316 
Major ADG (vs none)    
1 0.658* 0.626* 0.698 
2 0.656* 0.536* 0.960 
3 0.544* 0.497* 0.737 
4 0.445* 0.720 0.921 
* significant at 95% confidence level 
Selected results from tables 5-2, 5-5, 5-6 
 
Higher enrollment in the care management programs (holding other effects constant) was shown 
therefore in younger and less multimorbid patients. Higher propensity to enroll was also found in 
black patients compared to white patients for the Medicaid plan, while the USFHP plan did not 
show a significant race effect. An Oregon study found no statistically significant differences in 
the trajectories of patients once enrolled in case management across different ethnicities 
differences (Quinones, Ramsey, Newsom, & Dorr, 2014), while a randomized control study that 
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provided culturally tailored care management interventions to black patients with diabetes did 
show a reduction in emergency department visits (Gary et al., 2004). The effect measured in 
black Medicaid patients were not likely due to the patients being younger and less multimorbid, 
given that these variables were included in the models and the results for the race variable were 
consistently significant across both patient and multi-level results, this would provide evidence 
of a genuine effect. 
 
Table 6-2 Patient factors with increased likelihood of member’s acceptance to join CM 
program: Three Health Plans 
 Odds Ratio Estimates 
Variable 
Medicaid 
(n = 6029) 
Employee 
(n = 2692) 
US Family 
(n = 2028) 
Age 18-34 v 35-64  1.239*a 1.475b 1.094 
Race    
  Black vs White 1.478* n/a 1.015 
Referral 2.243* 3.192* 1.810* 
Number of Specialties 1.099* 1.122* 0.969 
* significant at 95% confidence level, a Baseline Age 35-64, b Age 65+ 
Selected results from tables 5-2, 5-5, 5-6 
 
For all plans, members who had been referred to care management by a physician or other 
clinicians also showed increased enrolment. The referral of a patient to care management may be 
a result of increased support and encouragement a patient’s provider, or there may be underlying 
factors not measured in the claims data. Studies have concluded that the identification and 
participation of high risk patients for care management can be supported by a combination of 
referral by a patient’s primary care provider diagnoses based and predictive model screening 




Condition specific effects were found, but these varied between the three health plan sub-
populations, both with respect to which conditions showed significant enrollment effects, and 
also whether the condition was associated with increased or decreased enrollment rates. These 
effects may be related to the screening processes of patients, a potential confounder, rather than a 
direct effect on enrolment. There could also be interaction between these specific conditions and 
the other general morbidity effects, such as those associated with a patient having a chronic or 
multiple chronic diseases. 
 
In order to test if the effects found were at the patient level and might be due to higher level 
effects (e.g. region), multilevel models were tested on the Medicare population. The multilevel 
(random effects) models were created to test if there were regional and care manager global 
effects. These global effects were not found to be significant, and therefore patient level effects 
were confirmed. Furthermore, the multilevel effects models also produced results which 
generally confirmed those found with the original single level model. Specifically, enrolment 
was again found to be associated with younger patients (holding other factors constant), black 
patients, and those with less multimorbidity. The confirmation of these patient level effects may 
need to be considered in the design of future care management screening programs, to ensure 
that patients are approached to enroll with appropriate recognition of their likelihood of 
enrolment. Understanding why these factors appear to affect enrolment emphasizes the need to 
acknowledge that casemix differences are assessed when designing, implementing and 




6.2.3 Predicting patient participation 
Two types of models were explored. The first used claims and enrollment data variables that had 
been found to be associated with participation, and then applied the resulting odds ratios for each 
variable to produce a patient level probability of participation. The second type of model used 
additional patient reported variables from the Personal Wellness profile, and created a Care 
Management Participation Likelihood (CMPL) score based on each of the available consumer 
reported and administrative variables. The advantage of the first model type is its immediate 
ability to be applied to any routine claims data. The latter model offered more in depth patient 
beliefs and attitudes. Either predictive score could be applied (after further testing and 
replication) to help guide the care management outreach and enrollment process. 
 
Adding the personal wellness profile variables did add additional explanatory power to the 
participation model, but given the low level of completeness of this profile, further expansion of 
data collection would likely be needed for this expanded score to be feasible. 
 
For this Medicaid population the initial probability of a patient enrolling in a case management 
program after screening was 42.5%. Subsequent outcomes appeared to be conditional on the first 
outcome, such that the probability of a patient enrolling a second time, following an initial 
enrollment, was 88.1%, while the probability of enrolling after initially declining to enroll was 
much lower at 27.2%. This finding is important in understanding why those who have enrolled 
historically are likely to re-enroll in the future, while those who have declined historically are 




6.2.4 Cost and Utilization outcomes 
As noted in section 6.2.1 there is a need to recognize that there are potential differences in case 
management enrollment populations by type of morbidity. This could produce selection bias that 
could both positively and negatively affect any comparisons of outcomes. Firstly, a crude 
comparison was made of selected output between care management enrolled and non-enrolled 
patients across the three plans. Secondly, a comparison was made using paired matching (using 
PSM) of enrolled and non-enrolled patients. Finally, using four sub-population groups (discussed 
in the following section), a breakdown of the results by patient morbidity complexity was made 
to provide a differential analysis of outcomes.  
 
The analyses compared “outcomes” of those enrolled in care management to those not enrolled, 
using second year (12 months after screening) utilization measures, mean total cost, 
hospitalizations, and emergency visits. 
 
The unadjusted comparison across the three plans showed higher costs for those not enrolling in 
care management. For the Employee health plan, the mean costs were $3,312 (23,315 - 20,003, 
+14.2%) higher, and for the Medicaid plan the figure was $2728 (29,373 - 26,644, +9.3%). The 
utilization of hospital admissions and emergency visits were similar for the Employee plan 
between the two sub-populations, while Medicare care management non-enrolled patients had 
higher rates of admissions and visits. The Family Health plan had contrasting results to the other 
two plans, with reduced costs for those enrolled in care management of $1724 (29,432-31,156, -
5.9%), but these were not statistically significant. The differences in these crude outcome 
statistics may have been due to the differing patient factors for the Family Health plan 
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recognized in the initial analysis, but confounding was also a consideration. This concern 
regarding potential confounders led to the enhanced analysis using matched pairs methods.  
 
Two Propensity Score matching (PSM) methods were used, to help ensure that all patients 
enrolled in care management programs (the “treatment” group) had a matched pair who had not 
enrolled (“control”) based on having as close as possible risk of participation. Despite the 
differences in the two methods applied (Nearest neighbor and Caliper), the results were broadly 
similar providing confidence in the overall direction of the cost reductions shown. After applying 
the PSM methods the Employee plan showed cost reductions for those enrolled in care 
management of $4486.86 (18.3%) and $4186.91 (17.1%), respectively for Nearest Neighbor and 
Caliper matching, this was higher than the non-matched. The Medicaid plan PSM results showed 
reduced costs of $4074.07 (13.3%) and $1372.66 (4.6%), and the Family Health plan also 
showed cost reductions for those enrolled in care management of $2458.51 (7.3%) and $2604.29 
(7.7%). These results were similar to those in a previous study that showed savings from disease 
management plans (Grossmeier et al., 2013), where the Employee and Medicaid health plans 
both showed a decreased adjusted cost for patients who enrolled in care management of $4233 
($352.75 per month). Costs savings in a Medicaid care management program had been attributed 
to reduced hospitalization and specialist visit costs (Picariello, Hanson, Futterman, Hill, & 
Anselm, 2008). 
 
The PSM results suggested that inpatient hospitalization and emergency visit rates were reduced 
for care management enrollees in the Medicaid population, but the other two plans did not show 
significant changes. This may indicate that the cost savings were not necessarily realized through 
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systematic reduction in patient utilization and claims. An Illinois Medicaid case management 
program showed costs savings, with lower inpatient admissions, outpatient visits, and improved 
quality   (Phillips, Han, Petterson, Makaroff, & Liaw, 2014). Mixed results for case management 
were found in the review conducted by Stokes and colleagues (Stokes et al., 2015) where no 
significant difference in costs were found across 36 studies, but concluded that case management 
delivered by multi-disciplinary teams may increase effectiveness. 
 
The use of propensity score matching demonstrated the need to apply comparative methods to 
reduce risk of confounding caused by selection bias. Although the crude analysis had shown cost 
reductions for two of the populations, the adjusted analysis demonstrated potential savings for all 
three plans. To gain a better understanding of the differences within the plan populations, further 
analysis was carried out using four sub-population groups defined by type of morbidity. 
 
6.2.5 Sub population analysis 
Four morbidity complexity groups were formed from the exploratory factor and clustering 
analyses. These groups were used to investigate further the within-population differences in cost 
and utilization outcomes. These four groups were comprised of patients with: 
 less than two chronic conditions; 
 two or more chronic conditions but with less than three Major Aggregated Diagnoses 
Groups (ADG); 
 three or four Major ADG; 




These four groups made up respectively 16.4%, 40.5%, 30.8% and 12.2% of the patients in the 
outcomes analyses, and made up 8.2%, 32.3%, 38.0% and 21.5% of the total costs in the second 
year. Overall the lower costs for care management enrolled patients compared to the non-
enrolled, summarized in the previous section, held for each of the sub-groups except the fourth 
most complex group. The reductions in costs for the enrolled populations were consistently 
lower for both of the matched pairs methods. While matched paired methods still showed higher 
costs for enrolled patients for the high complexity sub-group, the differences in costs were 
reduced compared with the all data (crude) results. Overall is was observed that as the 
complexity of the sub-groups increases, care management enrolment increases claims costs over 
those who are not enrolled. The reduced costs are for those who are less multimorbid within the 
population screened for care management. The larger difference in costs between patients with 
lower risk, compared to higher risk patients where the difference narrowed, had been previously 
reported by Sylvia and colleagues in a quasi-experimental study that selected a sample of 
patients who received usual care and patients who received Guided Care (Sylvia et al., 2008). 
 
While overall these results show favorable outcomes for patients who participate in care 
management, they may highlight a need to review the most complex patients in the care 
management programs. This would be in order to understand whether their increased costs are a 
direct consequence of providing case management and identifying needs for care that would 
otherwise be reduced or ignored for patients who chose not to enroll in care management, or if 
other factors not available in routine claims data are relevant. Coupled with the initial finding 
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that participation in care management reduces with increased multimorbidity, this represents an 
important consideration in future care management program design. 
 
6.3 Discussion 
6.3.1 Available Data Limitations and the Future 
While the study had a wide range of data available for the analysis, there were certain data 
related limitations. For example, only a limited exploration of enriched data, such as the Personal 
Wellness Profile, showed that the use of specific patient reported factors could add additional 
value to understand care management engagement. The factor analysis in section 5.3 produced 
five factors from the data, three of which cover constructs not available in the claims data: 
readiness to change exercise, nutrition and weight; readiness to reduce smoking and alcohol; 
health perception and social support. The other factors can largely be derived from current 
claims data, such as measures of multimorbidity, and whether preventative examinations have 
been undertaken. This latter factor does however highlight the importance of having longitudinal 
linked population health records, so that history of preventative examinations and procedures can 
be associated with current patient activities, particularly when these items were linked with 
continuous health plan enrolment (continuous plan enrollment of at least 12 month). Claims data 
is a good predictor of the need for case management, and is also powerful due to its availability 
at the time of screening, while other health risk data may not be available (Drozda, Libby, 




The potential of Electronic Medical Record (EMR) data could not be explored within the scope 
of this study. However there does exist a huge potential for other constructs associated with 
participation and patient engagement to be explored. The claims data did not allow for the 
specific nature of the care management intervention to be identified, and there was therefore no 
ability to delineate activity associated with the normal process of care and that attributed to the 
care management process. 
 
6.3.2 Patient Factors in Engagement in Care Management 
A troubling finding in this study is that high morbidity burden is associated with lower likelihood 
of care management enrollment.  Some explanations are that those patients currently receiving 
high levels of healthcare for their conditions may be content with current support, feel 
overwhelmed by the introduction of an additional care process, or may have lowered capacity to 
make the decision to take advantage of this likely beneficial service. The concept of a “Mental 
Bandwidth” has been postulated for people with multiple medical and socioeconomic challenges. 
This effect may be a contributing factor for members not enrolling or continuing their enrolment 
in case management from the Medicaid plans (Mani, Mullainathan, Shafir, & Zhao, 2013; 
Novotney, 2014). By extension, this effect may also inhibit individuals in effective self-
management and making decisions in support of their wellbeing. 
 
Lack of “Bandwidth” may explain why patients with high multimorbidity are less likely to enroll 
more generally than just those in poverty. With multiple medical conditions, high utilization of 
healthcare resources, multiple interactions with many health care professionals, the addition of 
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another consideration, i.e. care management, may be too much for an individual to be able to 
contemplate. Alternatively, the patient may also feel that they have sufficient healthcare support 
and the addition of care manager is unnecessary. 
 
6.3.3 Implications for Care Management Plans 
As noted, this study suggests that as multimorbidity increased, individuals were less likely to 
enroll in care management. Provided that care management is effective for these populations 
both in terms of improved quality and efficiency, this finding would suggest that approaches to 
care management programs may need to be modified to be more attractive to these very high 
morbidity individuals, for who these programs were specifically designed. Potential changes 
could include increased flexibility in approach, attention to tailored care plans, and closer 
coordination with the patient’s PCP and current team of physicians, lead physicians or other 
clinical professionals. The finding that enrollment was higher among those who were referred 
suggests including the patient’s physicians from the start provide encouragement and support for 
individuals. This may also indicate that certain outcomes that make a significant difference in 
engagement are attributable to the participation of physicians rather than the efficacy of the 
patients per se, and future studies should test if active physician participation contributes in care 
management programs to long-term patient self-efficacy. Finding that those patients who have 
enrolled historically are likely to re-enroll in the future, while those who have declined 
historically are most likely to continue to decline enrollment, presents further challenges to 
future studies to understand the underlying reasons for individuals to decline enrollment, and 
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whether there is the ability to adapt care managements programs, or the approaches to patients, 
to improve participation and enrollment. 
 
Hong and colleagues in reviewing the success factors for care management programs highlighted 
that the need to ensure programs were customizable and adapted to local factors  (Hong et al., 
2014). The issue of the size of program populations is an important consideration in adaptation, 
with small populations and practices needing to collaborate to share expertise and realize the 
benefits of care management, while larger programs and populations should “embed” care 
managers in practices. The review also reported that team and change culture within individual 
practices were important factors in the acceptance and success of care management. In common 
with approaches suggested by Shadmi and Freund, Hong et al also recommended a combined 
approach to selecting and screening patients (Shadmi & Freund, 2013). This combined approach 
involves the combination of screening algorithms and clinician referral as complementary 
methods, but also applying algorithms and clinical screening criteria to multiple considerations. 
Screening algorithms have been used by a number of studies which specially target patients who 
are at risk of high future costs, but equally valid are algorithms that are targeted at the likelihood 
of hospitalizations and emergency department visits. The application of multiple screening 
applications helps to ensure the application of a more comprehensive definition of at risk 
patients. While referral is a useful process to allow physicians and clinicians to identify high risk 
patients, there may be bias in the referral process towards patients who are difficult to manage as 




Individuals who do not enroll or actively participate in care management may be labelled as “non 
amenable”, and potentially excluded from consideration in the design of programs. As Wallace 
(Wallace, 2010) identified there are multiple types of engagement, and some highly engaged 
individuals may be highly selective in the interventions they see as suitable for themselves.  This 
behavior may be seen as non-compliant by providers. It is therefore important to ensure that care 
management programs are not just designed for those who show favorable behaviors, and are 
targeted at those individuals. Such an approach risks excluding individuals with genuine health 
needs, who are highly engaged in their own health care and needs, who need direct support and 
outreach to encourage self-management and assist them in advocating for their health 
requirements. Patients such as those identified by Dettalo, who undertook self-management 
education but were dissatisfied with their health providers, could be excluded systematically 
from relevant programs if customizable programs are not provided, or where screening for 
patients is not comprehensive (Dattalo et al., 2012). 
 
6.4 Study Strengths and Limitations 
This study developed an approach to define engagement and to explore the factors influencing a 
patient’s engagement in care management programs. As a research study it is seeking to build on 
the current knowledge and fulfill one of Gliner and Morgan’s (Gliner & Morgan, 2000) 
characteristics of a good research problem, i.e. ‘hold the promise of filling a gap in the 
literature’. Quasi-experimental design such as employed here has certain limitations with respect 
to the validity of any findings, but these can be mitigated in part by the use of pre and post 
observations, multiple measures and time-periods, multiple populations and large sample base. 
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Two major advantages of the extensive use of secondary data are realized in this study, being 
low cost and unobtrusive (Weiner, Powe, Steinwachs, & Dent, 1990). Regarding external 
validity, the study draws from three distinct populations but all are from the State of Maryland. 
In addition, there are multiple effects from other programs and treatments. As the study proposes 
the development of a new measure, the CMPL score, steps were applied to begin to test the 
reliability and validity of the measure. 
To mitigate against selection bias due to a non-randomized design the outcomes were tested 
using Propensity Score Matching (PSM), however the results may be subject to bias with respect 
to omitted variables. This relates to a key assumption in the PSM approach is conditional 
independence. This is that there are is a given set of covariates which are observable, not affected 
by the intervention, and the outcomes are independent of the assignment to ‘treatment’ or 
‘control’ (Caliendo & Kopeinig, 2008). Specifically, any variables that affects an individual 
enrolling in care management and subsequent outcomes, are included in the model, and 
therefore, there are no unobserved variables affecting enrollment. The PSM caliper method 
censored patients who did not have a close match and therefore the choice of the parameters 
using this method will affect the level of censoring. The level of censoring was particularly 
pronounced for the Medicaid plan data in this study, but it was felt that the addition of the PSM 
nearest neighbor method which does not censor mitigated against this risk. 
 
Patient engagement and participation is a current issue in managed care in the US. But it has not 
been well described or fully measured on a basis with available data such as routine claims or 
electronic medical records. This study sought to provide a stronger definition and practical 
measurement to aid the identification of influencing factors and thus provide for targeted 
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interventions in the future to improve the health status and treatment of patients with chronic 
conditions. The lack of any data regarding the care management interventions does however 
limit any direct conclusions with respect to specific interventions and programs being drawn. 
 
The linkage of care management records to the claims data resulted in a number of duplicate 
records being deleted, which introduced potential bias, although this would be small as the 
affected members were less than 0.77% of the study population (141 of 18413). The missing care 
management records for moderate risk members may reflect a recording bias, however these 
omissions were due to patients who could not be followed up immediately following each 
screening period. The demographic data was compared for these members and discussed with the 
care management team, no systematic bias was found and therefore the censoring of data was 
assumed to be random. 
 
Survey responses, such as those for the Personal Wellness Profile (PWP), are subject to response 
bias, non-response bias, and censoring. The survey was only available for the Employee health 
plan, and represented 30.9% of the screened population for that plan. The survey responses had a 
higher proportion of care management enrollees than for the whole screened population, a higher 
proportion of women, and the respondents were younger with a lower level of chronic conditions 
and multimorbidity. These findings are similar to those found by Merrill and Hull for the PWP 
and observed that participants in the survey may be more likely to submit health claims but less 
likely to participate in wellness programs (Merrill & Hull, 2013). The use of the responses to this 
survey should therefore be considered in the context of these biases. Temporal effects may be 
considered to provide additional confounding, with results taken at different intervals prior to the 
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screening for care management. The provision of a model using these data, and models 
excluding these data items should form the basis of a comparative evaluation to understand the 
potential for bias to or against respondents of such a survey. 
 
More generally, temporal effects are difficult to assess with limited data. Further years of data 
would allow better assessment of the temporal effects, particularly the effect that previous 
decisions to enroll in care management have on future decisions. This study was not able, for 
example, to assess if individuals responded adversely to frequent requests to enroll in health 
programs.  
 
External factors may have been confounders during the data collection period, including changes 
in the health care system (Andersen, 1995). The time period was chosen in consultation with 
colleagues from JHHC, to be relatively stable and therefore minimize the potential effects of 
information system redesign, as well as changes to care management program design and 
screening approaches. Such effects would need to be considered for longer term studies.  
 
The Care Management data did not contain any data specific to the types of intervention 
undertaken, or specific responses from the member. Details of case management interventions 
are only available as written text within the case notes. This therefore means that this study did 
not make any attempt to categorize the types of interventions, only whether members had chosen 




The use of secondary data provides for potential limitations in the study, in particular the 
additional data provided by the Personal Wellness Profile represents a response bias to those 
members who completed the survey. The variables in these data were therefore only used to 
explore the relationship between factors and were not used in the exploratory analysis or the 
subsequent models. 
 
The principal outcome measured was the second year healthcare costs following screening. 
There are potential concerns that healthcare costs may be incomplete, or include variance that is 
not directly attributable to the care or program, but to variance in prices and non-standardized 
fee-for-service schedules. Utilization measures (hospitalization, outpatient and emergency room 
visits) were added as it is argued they have a more direct measure of impact on programs 
(Serxner, Baker, & Gold, 2006) than costs for evaluation. The use of two years of data in this 
study could potentially increase the risk of regression to the mean and selection bias. The 12 
months of data prior to screening (baseline), and 12-month post screening should be increased in 
a future study to establish an enhanced baseline and observation period. More detailed analysis 
could have been made using per member per month costs. The use of paired matching (PSM) 
methods was utilized to mitigate against selection bias, however the use of these retrospective 
techniques is still relatively recent and a more complete understanding of bias in these techniques 




6.5 Study Implications 
This study proposed the creation of a measure for participation, and the incorporation of such a 
measure into predictive models for high risk case management identification and stratification. 
The study presents a use of existing data to enhance the current processes within JHHC for 
identifying high risk patients and the issues associated with their participation and enrolment in 
care management programs. This represents an advance in the use of claims and administrative 
data that could be applied to other populations and for care management in other organizations. 
The identification of key patient factors and changes in the predictive models also provides an 
opportunity to advance the risk prediction in the healthcare environment through the use of 
models more applicable to the general population. 
 
The literature regarding care management has found in some studies that quality of care and 
patient satisfaction is higher amongst those who enroll and participate. But the mixed results 
with regard to cost savings presents a challenge to perpetuating care management in its current 
form. The recent report from the Commonwealth Fund, highlights the challenges facing care 
management programs, and the need for ongoing evaluation and refinement (Blumenthal et al., 
2016). The methods and results of this study reflect the need to utilize multiple tools to screen 
and identify patients in need of care management, and likewise evaluation of the programs 
requires consideration using multiple metrics. The patient factors found to be associated with 
participation, such as the reduction in enrollment in care management as multimorbidity 
increases, illustrates the need to ensure that programs are appropriately designed for, and 




6.6 Areas for Future Research 
This chapter has raised a number of potential questions to be investigated in further research. 
These include investigations involving potential new data, further examination of effects found 
in the study, and a better understanding of potential alternative care management approaches for 
high multimorbidity patients. 
 
The increased recording and availability of electronic health record (EHR) and personal health 
record (PHR) data provides a potential to investigate additional variables that describe other 
elements of engagement and participation. The study identified specific items provided by the 
personal wellness profile that could add explanatory power to a risk model, if they were collected 
from a higher proportion of patients. The claims data did not allow for the specific nature of the 
care management intervention to be identified, therefore the collection and identification of data 
that delineates normal process of care and that attributed to the care management programs, such 
that the direct and indirect effects of the care management process could be studied. It would 
also be advantageous to record the type of care management intervention, whether the patient or 
the plan had dis-enrolled, and the extent to which the intervention had been completed. 
 
The use of the SAS statistical software limited the creation of sub-population groupings to 
Principal Component Cluster Analysis. Alternative classification approaches to creating sub-
population groups such as Classification and Regression Trees (Brieman, Friedman, Olshen, & 




The race and referral effects could be investigated further to understand if these are observable in 
other care management populations, particularly Medicaid, and if these are related to race and 
gender concordance between patients, family, providers, and social support. The referral effect 
could be investigated to examine if it is specific to providers, care managers or result of a multi-
disciplinary care team approach. This study was not able to examine whether or how 
participation was linked to social factors, and whether patients in poverty or with scarce 
resources are more likely to enroll. 
 
In considering patient cognitive ability, does the concept of ‘Bandwidth’ explain why patients 
with high multimorbidity are less likely to enroll more generally that just those in poverty? Do 
patients with high multimorbidity, and interacting with multiple care professionals, lead them to 
be more likely to decline additional services such as care management? 
 
Further understanding needs to be gained to understand why patients do not enroll in care 
management, and particularly those with high multimorbidity for who the case management 
programs have been targeted. Such a study would also need to examine whether existing care 
management approaches are appropriate for the very highest multimorbid patients, given the 
findings of this study, that higher multimorbid patients are less likely to enroll in care 
management and have higher costs if they do. This study was not able to examine the effect of 
alternative interventions for high multimorbid patients such as Case Management, Telephonic 
Case Management, watchful waiting, Medical Care homes and Primary Care Medical Care 
homes (Wise, Bahl, Mitchell, West, & Carli, 2006). Finally, this study was only able to observe 
12 months’ post screening in the outcomes analysis, but such a time period may not be sufficient 
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to realize the benefits of care management sufficiently. It is therefore important to gain an 
understanding of over what time periods (continuous and discontinuous) should benefits of 
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8.1 Variable list  
Variable Type Description Source 
Member demographic data 
Age Continuous Patient age in years JHM Population Health 
Data 
Gender Dichotomous Patient gender, Male/Female ditto 
Zip Code Categorical 5-digit Patient’s residential Zip code. ditto 
Region Categorical Patient’s residential County: 
Baltimore City Region = Baltimore City 
Central Region = Carroll, Harford, Baltimore, Howard, Anne 
Arundel 
Southern Region = Calvert, Charles, St Mary’s 
Western Region = Garrett, Allegany, Washington, Frederick 
Upper Shore Region = Caroline, Cecil, Kent,Queen Anne’s, 
Talbot 
Lower Shore Region = Dorchester, Somerset, Wicomico, 
Worcester 
Other Region = Any Other 
ditto 
JHHC Line of Business Categorical The JHHC Health Plan of the patient. Plans include EHP or 
Priority Partners 
ditto 
Duration of plan eligibility Categorical/ 
Continuous 
Length of time the patient has been eligible for the health plan. ditto 
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Variable Type Description Source 
Ethnicity/Race  Categorical Patient’s ethnicity/race: non-Hispanic White, non-Hispanic 
Black, Hispanic, Asian/Pacific Islander, American 
Indian/Alaska Native, and Unknown/Other 
ditto 
Social/economic status Categorical 
 
JHM Population Health 
Data 
Total Cost of Care  Continuous Annualized total cost of care ditto 
Phamacy Cost Continuous Annualized total cost of pharmacy ditto 
Utilization data 
Primary care type Categorical 
 
JHM Population Health 
Data / JH Community 
Physicians EMR 
Secondary care type Categorical 
 
ditto 
Primary Care visits Continuous Annualized count of Primary Care visits ditto 
Specialist Care encounters Continuous Annualized count of Specialist Care encounters ditto 
ER Visits Continuous Annualized count of Emergency Room Visits ditto 




Dicotomous Enrolled, Not Enrolled JHM Population Health 
Data 
Duration of Enrollment Continuous Count during year of days in enrollment ditto 
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Variable Type Description Source 
Gaps in Enrollment Continuous Count during year of breaks in enrollment ditto 
Screening Stratification Categorical The risk stratification assigned to the patient by the JHHC 




HbA1C test marker Dicotomous Hemoglobin A1c (HbA1C) test undertaken: Yes, No JHM Population 
Health Data / JH 
Community 
Physicians EMR 
HbA1C value Continuous Hemoglobin A1c (HbA1C) test value ditto 
Blood pressure Categorical 
 
ditto 
BMI Continuous Body Mass Index ditto 
Eye examination Dicotomous Annual ophthalmic eye examination: Yes, No ditto 
Foot examination Dicotomous Annual foot examination: Yes, No ditto 




Diagnoses Codes Categorical ICD9CM diagnoses codes attributed to an individual JHM Population 
Health Data 
Pharmacy Codes Categorical NDC pharmacy codes attributed to an individual ditto 
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Variable Type Description Source 
adg_codes Categorical Aggregated Diagnosis Groups (ADG) attributed to patient: 01-
34 
ditto 
adg_vector Categorical Aggregated Diagnosis Groups represented as a binary vector. JHM Population 
Health Data 
edc_codes Categorical Expanded Diagnosis Clusters (EDC) attributed to patient ditto 
rxmg_codes Categorical Rx-Defined Morbidity Groups (Rx-MGs) attributed to patient ditto 
major_rxmg_codes Categorical Major Rx-Defined Morbidity Groups (Rx-MGs) attributed to 
patient 
ditto 
major_adg_count Continuous Count of Major Aggregated Diagnosis Groups ditto 
frailty_flag Dicotomous Marker indicating if the patient has a diagnosis falling within any 
1 of 11 clusters that represent medical problems associated with 
frailty 
ditto 
hospital_dominant_count Continuous A count of Hospital dominant conditions, diagnoses that are 
associated with a greater than 50 percent probability among 
affected patients of hospitalization in the next year 
ditto 
chronic_condition_count Continuous A count of EDCs containing trigger diagnoses indicating a 
chronic condition with significant expected duration and 
resource requirements. 
ditto 
asthma_condition Dicotomous Asthma diagnosis marker, A flag indicating if this patient has 
this medical condition and how it was indicated (NP=Not 
Present, ICD=ICD Indication, Rx=Rx Indication, BTH=ICD 
and Rx Indication, TRT=Meets Dx/Rx treatment criteria). 
ditto 
arthritis_condition Dicotomous Arthritis diagnosis marker ditto 
CHF_condition Dicotomous Congestive Heart Failure diagnosis marker ditto 
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Variable Type Description Source 
COPD_condition Dicotomous Chronic Obstructive Pulmonary Disease diagnosis marker ditto 
CRF_condition Dicotomous Chronic Renal Failure diagnosis marker JHM Population 
Health Data 
depression_condition Dicotomous Depression diagnosis marker ditto 
diabetes_condition Dicotomous Diabetes diagnosis marker ditto 
hyperlipidemia_condition Dicotomous Hyperlipidemia diagnosis marker ditto 
hypertension_condition Dicotomous Hypertension diagnosis marker ditto 
IHD_condition Dicotomous Ischemic Heart Disease diagnosis marker ditto 
low_back_pain_condition Dicotomous Low Back Pain diagnosis marker ditto 
unscaled_total_cost_resourc
e_index 
Continuous Unscaled Total Cost Resource Index. ACG Predictive Model 
(ACG-PM) Predicted Resource Index (PRI) for Total Cost -- 
the estimated total costs (including pharmacy costs) for this 
patient for the year following the observation period. Based 
upon a reference database (with a mean of 1.0), the predicted 




Continuous Rescaled Total Cost Resource Index. The Total Cost Resource 
Index rescaled so that the local population mean is 1.0. 
Subgroup analyses provide comparisons to local norms. 
ditto 
probability_high_total_cost Continuous ACG Predictive model Probability High Total Cost. ACG-PM 
Probability Score for total cost, the probability that the patient 
will have high total costs (including pharmacy costs) in the year 




Variable Type Description Source 
unscaled_pharmacy_cost_re
source_index 
Continuous ACG Predictive model Unscaled Pharmacy Cost Resource 
Index. ACG-PM PRI Score for Pharmacy Costs -- the estimated 
pharmacy costs for this patient for the year following the 
observation period. Based upon a reference database (with a 






Continuous ACG Predictive model Rescaled Pharmacy Cost Resource 
Index. Indicates that this patient has high risk of an 





Continuous ACG Predictive model Probability High Pharmacy Cost. 
Probability that the patient will have unexpectedly high 
pharmacy costs in the year following the observation period. 
ditto 
JHHC Care Management Program Patient Survey data 
Activation Score Continuous Score from Patient Activation Measure (PAM), with a 
theoretical range from 0 to 100 (increasing activation) 
JHHC PAM 
Physical Health Composite 
Score (PCS) 
Continuous Composite score with range from 0 to 100, zero score indicates 
lowest level of health, 100 indicates the highest level of health. 
JHHC SF-12 
Mental Health Composite 
Scores (MCS) 
Continuous Composite score with range from 0 to 100, zero score indicates 






8.2 Personal Wellness Profile 
Variable Type Description Source 
General Health Perception 
(PWP #2) 
Ordinal Personal Wellness Profile Concise Assessment questionnaire. 
#2 General Health: excellent; very good; good; fair; poor. 
JHHC PWP 
Social support (PWP #29) Dicotomous Personal Wellness Profile Concise Assessment questionnaire. 
#29 Social support: yes, no 
 
Last physical exam (PWP 
#34) 
Ordinal Personal Wellness Profile Concise Assessment questionnaire. 
#34 Last physical exam, within the last: year, two years, three 
years, four years, five or more. 
 




Personal Wellness Profile Concise Assessment questionnaire. 
#37 Preventive exams: bowel exam, dental exam, flu shot. 
 
Readiness to change (PWP 
#38) 
Ordinal (5 point 
scale, 7 
variables) 
Personal Wellness Profile Concise Assessment questionnaire. 
#38 Readiness to change: 1.be physically active; 2.practice 
good eating habits; 3.avoid smoking or using tobacco; 4.lose 
weight, or maintain healthy weight; 5.handle stress well; 





8.3 Additional Results 
This section contains additional results to those in Chapter 5. These represent supplemental 
analysis, or detailed results where summaries were provide in the results chapter.  
8.3.1 Missing Data 
Case management enrollment outcomes were present for all high risk (“Level 1”) screened 
patients, but missing for some moderate risk (“Level 2”) patients. For members screened from 
the Priority Partners plan there were 5451 records without a recorded outcome, and 2871 records 
with an outcome. It was assumed the members without an outcome were not followed up during 
the screening period, but were subsequently reentered into the screening algorithm the 
succeeding month. This assumption was confirmed by the case management team. Key 
characteristics of the records were examined to indicate any bias in the underlying populations. 
Table 8-1 shows the mean (and standard deviation) of the variables. These results were examined 




Table 8-1: Demographic Characteristics: Medicaid plan, CM Moderate Risk ‘Level 2’ Screened, 
Mean (sd) 
Characteristic 
CM Records with 
missing CM Outcome 
CM Records with 
CM Outcome 
N 5451  2871  
Female 0.7265 (0.4458) 0.7548 (0.4303) 
Region 
  Baltimore City 0.3654 (0.4816) 0.5556 (0.4970) 
  Baltimore County 0.1257 (0.3315) 0.0878 (0.2830) 
  Eastern Shore 0.2620 (0.4397) 0.1877 (0.3906) 
  Southern 0.1624 (0.3688) 0.1069 (0.3091) 
Age at Screening 45.9518 (11.064) 43.3696 (12.494) 
Race 
  Black 0.4861 (0.4999) 0.6047 (0.4890) 
  White 0.4364 (0.4960) 0.3197 (0.4665) 
  Other 0.0360 (0.1862) 0.0300 (0.1705) 
Chronic Conditions 4.2434 (2.4212) 4.1365 (3.0081) 
Major ADGs 1.9176 (1.3224) 2.0596 (1.5853) 
Frailty 0.2491 (0.4325) 0.2720 (0.4451) 
Probability IP Hospitalization 0.2008 (0.1415) 0.2261 (0.1859) 
Rescaled Total cost index 5.5923 (3.0042) 6.1651 (4.5205) 
Generic Drug count 15.6894 (7.6085) 14.4657 (8.7739) 
Unique Provider count 4.3244 (2.7731) 4.3265 (2.8998) 
Specialty count 3.5654 (2.0473) 3.4404 (2.0900) 
Plan Enrollment   
  Enrolled > 6mth 0.8586 (0.3485) 0.8513 (0.3559) 
  Enrolled > 12mth 0.8011 (0.3992) 0.7388 (0.4394) 
Condition Prevalence 
  Asthma 0.5584 (0.4966) 0.5340 (0.4989) 
  Rheumatoid Arthritis 0.0330 (0.1787) 0.0313 (0.1743) 
  Congestive Heart Failure 0.0915 (0.2884) 0.1153 (0.3194) 
  Depression 0.5252 (0.4994) 0.4483 (0.4974) 
  Diabetes 0.5505 (0.4975) 0.4044 (0.4909) 
  Lipidemia 0.5241 (0.4995) 0.4131 (0.4925) 
  Hypertension 0.7489 (0.4337) 0.6621 (0.4731) 
  Ischemic Heart Disease 0.1048 (0.3063) 0.1069 (0.3091) 






8.3.2 Logistic Regression – Medicaid plan, Second outcomes 
The following tables Table 8-2 and Table 8-3 are the outputs of logistic regression models from 
the Medicaid data. The dependent variable is the second outcome (enrollment in care 
management program, or non-enrollment) for a patient, given an initial outcome. Table 8-2 
shows the odd ratios for the second outcome for all patients who had enrolled in care 
management following the first screening. 
 
Table 8-2 Impact of factors on predicting member’s acceptance to join CM program: 
Medicaid population, Second Outcome where First accepted CM 
Effect 
Odds Ratio 
Estimate 95% CL 
Gender Male vs Female 1.095 0.825 1.454 
Region    
  Central vs Baltimore City 3.196 0.950 10.759 
  County vs Baltimore City 1.551 1.001 2.405 
  Eastern Shore vs Baltimore City 1.531 1.089 2.151 
  Other vs Baltimore City 1.486 0.187 11.806 
  Southern vs Baltimore City 1.82 1.260 2.629 
  Western vs Baltimore City 1.668 0.829 3.354 
Age 35-64 (base 18-34) 1.233 0.904 1.682 
Race    
  Black vs White 0.953 0.712 1.274 
  Other vs White 1.645 0.495 5.472 
  Unspecified vs White 0.846 0.5 1.433 
Primary Care Provider Multiple vs 1 0.465 0.357 0.606 
Chronic Conditions (vs none)    
1 2.056 0.940 4.498 
2 1.998 0.954 4.183 
3 1.803 0.843 3.857 
4 2.046 0.919 4.555 
5 1.161 0.533 2.529 
  6+ 0.885 0.407 1.923 
Major ADG (vs none)    





Estimate 95% CL 
2 0.938 0.482 1.826 
3 0.822 0.416 1.623 
4 0.55 0.278 1.087 
Frailty 1.335 1.019 1.748 
Referral 0.599 0.312 1.149 
Generic drug count 0.993 0.975 1.011 
Unique Provider Count 0.936 0.862 1.016 
Number of Specialties 1.103 0.975 1.248 
No Generalist 1.002 0.540 1.860 
Condition    
  Asthma 1.046 0.803 1.363 
  Rheumatoid Arthritis 0.602 0.343 1.058 
  Congestive Heart Failure 0.788 0.567 1.094 
  Depression 1.096 0.831 1.447 
  Diabetes 0.818 0.623 1.075 
  Disorders of Lipid Metabolism 1.574 1.154 2.147 
  Hypertension 1.283 0.938 1.757 
  Ischemic Heart Disease 1.044 0.692 1.575 
Enrollment in Health Plan    
  6 months 1.011 0.601 1.700 
  12 months 0.463 0.319 0.671 
Medicaid plan, Screened for Care Management High and Moderate Risk 
Second Outcome where First accepted CM, n = 2814, probability = 0.8813 
Baseline odds for a Female aged 18-34, White, Baltimore City = 13.7701 





Table 8-3 shows the odd ratios for the second outcome for all patients who had not enrolled in 
care management following the first screening.  The dependent variable is the second outcome 
(enrollment in care management program, or non-enrollment) for a patient, given an initial 
outcome.  
 
Table 8-3 Impact of factors on predicting member’s acceptance to join CM program: 
Medicaid population, Second Outcome where First declined CM 
Effect 
Odds Ratio 
Estimate 95% CL 
Gender Male vs Female 1.092 0.942 1.266 
Region    
  Central vs Baltimore City 0.656 0.366 1.177 
  County vs Baltimore City 0.818 0.651 1.027 
  Eastern Shore vs Baltimore City 0.77 0.645 0.92 
  Other vs Baltimore City 1.011 0.485 2.108 
  Southern vs Baltimore City 0.916 0.748 1.122 
  Western vs Baltimore City 0.718 0.516 0.997 
Age 35-64 (base 18-34) 0.889 0.737 1.073 
Race    
  Black vs White 1.072 0.927 1.24 
  Other vs White 1.187 0.757 1.86 
  Unspecified vs White 1.05 0.784 1.406 
Primary Care Provider Multiple vs 1 1.536 1.34 1.761 
Chronic Conditions (vs none)    
1 1.441 0.66 3.148 
2 1.25 0.578 2.703 
3 1.773 0.826 3.805 
4 1.654 0.769 3.558 
5 1.878 0.869 4.061 
  6+ 1.785 0.827 3.853 
Major ADG (vs none)    
1 0.749 0.456 1.231 
2 0.780 0.479 1.272 
3 0.887 0.544 1.447 
4 0.805 0.495 1.31 





Estimate 95% CL 
Referral 2.697 1.881 3.866 
Generic drug count 0.997 0.988 1.007 
Unique Provider Count 1.026 0.984 1.07 
Number of Specialties 0.997 0.936 1.062 
No Generalist 0.874 0.608 1.258 
Condition    
  Asthma 1.122 0.974 1.292 
  Rheumatoid Arthritis 1.012 0.738 1.388 
  Congestive Heart Failure 1.237 1.056 1.449 
  Depression 1.146 0.991 1.326 
  Diabetes 1.093 0.942 1.268 
  Disorders of Lipid Metabolism 0.960 0.821 1.123 
  Hypertension 1.022 0.85 1.228 
  Ischemic Heart Disease 1.035 0.864 1.24 
Enrollment in Health Plan    
  6 months 0.842 0.637 1.115 
  12 months 1.760 1.462 2.119 
Medicaid plan, Screened for Care Management High and Moderate Risk 
Second Outcome where First declined CM, n = 5009, probability = 0.2715 
Baseline odds for a Female aged 18-34, White, Baltimore City = 0.0537 





8.3.3 Logistic Regressions – Random Effects Models 
The following tables, Table 8-4, Table 8-5, and Table 8-6 show the odds ratios produced by the 
three random effects models: ‘region’; ‘care manager’; and ‘region’ with ‘care manager’ level. 
The three models were derived to test for global effects that were independent of patient level 





Table 8-4 Impact of factors on predicting members’ acceptance to join CM program: Care 





Gender Female vs Male 1.068 0.934 1.222 
AgeBand3 18-34 v 35-64 1.401 1.21 1.622 
Race    
  Black vs White 1.347 1.186 1.530 
  Other vs White 0.783 0.547 1.122 
  Unspecified vs White 1.194 0.915 1.558 
Primary Care Provider 1 v Multiple 1.659 1.427 1.929 
Chronic Condition    
  1 vs 0 1.917 1.365 2.691 
  2 vs 0 1.487 1.144 1.933 
  3 vs 0 1.416 1.135 1.766 
  4 vs 0 1.234 1.008 1.510 
  5 vs 0 1.314 1.080 1.599 
  6+ vs 0 1.142 0.939 1.389 
Major ADG    
  1 vs 0 1.926 1.478 2.509 
  2 vs 0 1.418 1.167 1.724 
  3 vs 0 1.511 1.269 1.800 
  4 vs 0 1.223 1.033 1.448 
Frailty N vs Y 0.982 0.861 1.120 
Referral 0.721 0.562 0.926 
Generic drug count 0.984 0.975 0.992 
Unique Provider Count 0.973 0.929 1.020 
Number of Specialties 1.115 1.043 1.192 
No Generalist N vs Y 0.878 0.72 1.069 
Enrollment in Health Plan    
  6 months 1.236 1.070 1.428 
  12 months 1.317 1.003 1.730 
Medicaid plan, Screened for Care Management High and Moderate Risk 
Baseline odds for a Male aged 35-64, White = 0.3300 





Table 8-5 Impact of factors on predicting members’ acceptance to join CM program: 





Gender Female vs Male 1.055 0.929 1.198 
AgeBand3 18-34 v 35-64 1.296 1.126 1.492 
Race    
  Black vs White 1.419 1.253 1.607 
  Other vs White 0.860 0.610 1.211 
  Unspecified vs White 1.186 0.924 1.522 
Primary Care Provider 1 v Multiple 1.589 1.377 1.833 
Chronic Condition    
  1 vs 0 1.801 1.279 2.535 
  2 vs 0 1.400 1.071 1.829 
  3 vs 0 1.371 1.097 1.714 
  4 vs 0 1.297 1.059 1.589 
  5 vs 0 1.304 1.077 1.578 
  6+ vs 0 1.234 1.023 1.487 
Major ADG    
  1 vs 0 1.759 1.371 2.256 
  2 vs 0 1.305 1.083 1.572 
  3 vs 0 1.321 1.120 1.558 
  4 vs 0 1.161 0.990 1.362 
Frailty N vs Y 0.958 0.847 1.083 
Referral 2.807 2.323 3.391 
Generic drug count 0.988 0.979 0.997 
Unique Provider Count 0.983 0.941 1.027 
Number of Specialties 1.085 1.019 1.156 
No Generalist N vs Y 0.876 0.777 0.987 
Condition    
  Asthma 0.728 0.539 0.983 
  Rheumatoid Arthritis 1.043 0.882 1.234 
  Congestive Heart Failure 0.920 0.814 1.040 
  Depression 0.910 0.801 1.033 
  Diabetes 0.962 0.838 1.104 
  Disorders of Lipid Metabolism 0.800 0.697 0.917 
  Hypertension 0.919 0.756 1.116 
  Ischemic Heart Disease 0.953 0.791 1.148 
Enrollment in Health Plan    
  6 months 1.044 0.910 1.197 
  12 months 1.224 0.939 1.595 
Medicaid plan, Screened for Care Management High and Moderate Risk 
Baseline odds for a Male aged 35-64, White = 0.1137 




Table 8-6 Impact of factors on predicting members’ acceptance to join CM program: 





Gender Female vs Male 1.056 0.921 1.210 
AgeBand3 18-34 v 35-64 1.325 1.137 1.544 
Race    
  Black vs White 1.370 1.202 1.561 
  Other vs White 0.796 0.555 1.143 
  Unspecified vs White 1.200 0.919 1.568 
Primary Care Provider 1 v Multiple 1.678 1.442 1.952 
Chronic Condition    
  1 vs 0 1.670 1.158 2.409 
  2 vs 0 1.311 0.983 1.749 
  3 vs 0 1.294 1.017 1.647 
  4 vs 0 1.152 0.927 1.431 
  5 vs 0 1.245 1.012 1.531 
  6+ vs 0 1.102 0.901 1.347 
Major ADG    
  1 vs 0 1.939 1.477 2.545 
  2 vs 0 1.438 1.174 1.761 
  3 vs 0 1.528 1.278 1.827 
  4 vs 0 1.224 1.032 1.451 
Frailty N vs Y 0.997 0.873 1.137 
Referral 0.739 0.575 0.948 
Generic drug count 0.986 0.976 0.996 
Unique Provider Count 0.974 0.929 1.021 
Number of Specialties 1.113 1.040 1.190 
No Generalist N vs Y 1.029 0.904 1.172 
Condition    
  Asthma 0.720 0.523 0.992 
  Rheumatoid Arthritis 0.992 0.831 1.186 
  Congestive Heart Failure 0.952 0.834 1.087 
  Depression 1.064 0.927 1.221 
  Diabetes 1.050 0.904 1.219 
  Disorders of Lipid Metabolism 0.761 0.657 0.883 
  Hypertension 0.884 0.718 1.089 
  Ischemic Heart Disease 0.866 0.711 1.056 
Enrollment in Health Plan    
  6 months 1.234 1.068 1.426 
  12 months 1.340 1.018 1.762 
Medicaid plan, Screened for Care Management High and Moderate Risk 
Baseline odds for a Male aged 35-64, White = 0.3893 




8.3.4 Year 2 Outcomes 
The following tables show alternative analyses for second year (following initial screening) from 
section 5.4. These were provided to colleagues in JHHC earlier in the study to provide feedback 
and suggestions for improvement or issues to investigate. 
 
Table 8-7 shows the overall mean costs (crude and modelled/expected) in the year after initial 
care management screening, for the 3 health plans, divided between patients who enrolled and 
those who did not enroll in care management. The Employee and Medicaid health plans show a 
lower mean cost in year 2 for those who enrolled in a Care Management program compared to 
those who did not enroll. The Family Health plan had a higher cost for Care Management 
enrollees compared to non-enrollees. The adjusted mean costs are shown in the table below, 
together with the adjusted Inpatient Rate and Emergency Rate in year 2. 
 
Table 8-7 Year 2 Total Cost by Health Plan, Care Management Enrolled v Not Enrolled 
Plan/Participation N Year 2 
Mean 
Cost $ (95% CI) 
Year 2 
Adjusted 
Cost $ (95% CI) 
Employee Health Plan      
CM Enrolled 923 20002.97 (17058-22948) 21095.32 (20014-22177) 
Not Enrolled 1442 23315.31 (20966-25664) 25328.72 (24406-26252) 
Medicaid Health Plan      
CM Enrolled 2331 26644.27 (24809-28479) 24730.17 (24097-25364) 
Not Enrolled 2935 29372.54 (27819-30926) 28797.62 (28241-29354) 
Family Health Plan      
CM Enrolled 581 31155.94 (27265-35047) 31413.93 (29968-32860) 
Not Enrolled 1122 29431.62 (26900-31964) 31292.32 (30236-32349) 
CI, Confidence Interval, CM, Care Management 
Adjusted: Sex, Age, Major ADG count, Year1 Cost 













(95% CI) Pr>|t| 
Employee Health 
Plan 
     
  
CM Enrolled 923 20002.97 (17057-22948) <.0001 20623.10 (19480-21765) <.0001 
Not Enrolled 1442 23315.31 (20966-25664) <.0001 23742.92 (22769-24715) <.0001 
Medicaid Health 
Plan 
       
CM Enrolled 2331 26644.27 (24809-28479) <.0001 25814.00 (25133-26494) <.0001 
Not Enrolled 2935 29372.54 (27818-30926) <.0001 28475.83 (27873-29078) <.0001 
Family Health Plan        
CM Enrolled 581 31155.94 (27264-35047) <.0001 33904.45 (32476-35332) <.0001 
Not Enrolled 1122 29431.62 (26899-31963) <.0001 31019.27 (29937-32100) <.0001 
CI, Confidence Interval, CM, Care Management 
Expected: Sex, Age, Major ADG count, Care Management Level, Year1 Cost 
Excludes patients with zero year 2 costs 
  
 
The adjusted mean costs are shown again in the table below, together with the adjusted Inpatient 
Rate and Emergency Rate in year 2. 
 
Table 8-9 Table Year 2 Mean Cost, Inpatient Rate, ER Rate by Health Plan, Care 
Management Enrolled v Not Enrolled 
Plan/Participation N 
Year 1 Mean 
Cost $ 
Year 2 





Employee Health Plan      
CM Enrolled 923 21320.77 20002.97 0.481 1.461 
Not Enrolled 1442 29970.53 23315.31 0.590 1.536 
Medicaid Health Plan      
CM Enrolled 2331 27168.33 26644.27 0.756 2.411 
Not Enrolled 2935 34789.56 29372.54 0.919 2.611 
Family Health Plan      
CM Enrolled 581 39949.7 31155.94 0.734 1.232 
Not Enrolled 1122 39536.76 29431.62 0.705 1.123 
*Adjusted: Sex, Age, Major ADG count, Year1 Cost 





Table 8-10 and Table 8-11 show two options of sub-group analysis for the three plan 
populations, which were produced for JHHC colleagues to review, prior to the PSM analysis 
being produced. The first shows grouping that reflect the structures of the existing analytical 
reports, i.e. whether patients were identified for screening by the algorithm, or if they had been 
referred, and if they were screened for high risk ‘level 1’ or moderate risk ‘level 2’. The second 
table shows the sub-groups derived from the factor and cluster analyses, based on the number of 
chronic conditions and major ADGS a patient had. 
 
Table 8-10: Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by 










Employee Health Plan     
 
CM Enrolled      
 
Level 1 Algorithm 264 31920.05 (23013-40826) 31104.34 (29002-33206) 
 
Level 1 Referral 225 19730.79 (15618-23843) 24576.58 (22939-26214) 
 
Level 2 Algorithm 208 11114.96 (9452-12777) 11357.39 (10640-12074) 
 
Level 2 Referral 190 7407.03 (6008-8805) 6700.68 (6312-7088) 
 
Not Population Db 36 52143.64 (33475-70812) 46066.07 (32434-59697) 
Not Enrolled      
 
Level 1 Algorithm 603 32844.19 (28192-37496) 31596.95 (30094-33099) 
 
Level 1 Referral 75 27099.19 (13901-40296) 28143.02 (25248-31037) 
 
Level 2 Algorithm 602 12124.49 (10881-13367) 14023.24 (13169-14877) 
 
Level 2 Referral 86 7048.33 (3762-10334) 7529.56 (6420-8638) 
 
Not Population Db 73 52144.24 (36615-67672) 52789.10 (47666-57911) 
Medicaid Health Plan      
CM Enrolled      
 
Level 1 Algorithm 756 30838.58 (28049-33628) 31912.26 (30832-32991) 
 
Level 1 Referral 713 24311.43 (20818-27803) 26335.73 (25505-27166) 
 
Level 2 Algorithm 203 18618.32 (14340-22895) 13308.04 (12363-14253) 
 
Level 2 Referral 409 8471.43 (7165-9777) 8374.90 (7781-8967) 
 
Not Population Db 250 56861.76 (47736-65987) 44570.09 (42143-46996) 
Not Enrolled      
 
Level 1 Algorithm 1279 38099.42 (35429-40769) 34117.56 (33386-34848) 
 













Level 2 Algorithm 842 17833.41 (16220-19446) 16251.26 (15635-16867) 
 
Level 2 Referral 140 8186.28 (5715-10657) 9526.04 (8294-10757) 
 
Not Population Db 326 39512.63 (33638-45387) 45330.59 (43341-47319) 
Family Health Plan      
CM Enrolled      
 
Level 1 Algorithm 264 33834.52 (27900-39768) 35559.14 (33373-37744) 
 
Level 1 Referral 203 24133.52 (18510-29756) 31245.91 (29517-32974) 
 
Level 2 Algorithm 34 21940.37 (13752-30128) 14420.92 (12588-16253) 
 
Level 2 Referral 12 5779.41 (3446-8112) 10133.88 (8377-11890) 
 
Not Population Db 68 50806.78 (34835-66778) 49353.47 (44967-53739) 
Not Enrolled      
 
Level 1 Algorithm 651 37397.07 (33655-41138) 34682.09 (33374-35989) 
 
Level 1 Referral 102 27765.99 (17374-38157) 35570.51 (32718-38422) 
 
Level 2 Algorithm 303 13470.74 (11989-14951) 17694.89 (16657-18732) 
 
Level 2 Referral 9 8492.53 (3882-13102) 11381.69 (6612-16151) 
 
Not Population Db 57 29589.31 (18330-40847) 54971.88 (47313-62630) 
CI, Confidence Interval, CM, Care Management 
Adjusted: Sex, Age, Major ADG count, Care Management Level, Year1 Cost 





Table 8-11 shows the outcome analysis for the 4 groups suggested by exploratory factor and 
cluster analysis. The first group includes all members with less than 2 chronic conditions. The 
other three groups include all members with 2 or more chronic conditions, and increasing 
numbers of Aggregated Diagnoses Groups (ADGs), such that the most complex group consists 
of members with 5 or more ADGs combinations. A comparison of claims costs in the second 
year within each of these complexity groups was made to examine whether the cost differences 
between those who enrolled in care management; and those who did not enroll changes as 
complexity changes. The cost ratio is the Year 2 mean cost for those enrolled in a care 
management program divided by the mean cost of those who did not enroll. 
 
The Medicaid plan had lower year 2 costs for those who enrolled for the two least complex 
groups of member, but the costs were higher amongst enrolled for the two complex groups. For 
the employee plan those who enrolled had lower costs for all but the most complex group. The 
Family health plan general produced higher costs in those who enrolled, except for the least 
complex group. While Table 8-11 showed that the overall costs for those who enroll are 
generally lower in year 2 that those who do not enroll, creating a breakdown by complexity 
suggests that as the complexity increases, care management enrolment increases claims costs 
over those who are not enrolled. The reduced costs are for those who are less multi-morbid 





Table 8-11 Mean Cost by Health Plan, Care Management Enrolled v Not Enrolled, by 










Employee Health Plan     
 
CM Enrolled      
 <2 Chronic Conditions 268 10579.13 (8508-12649) 12555.23 (11571-13539) 
 0-2 Major ADGs 489 18432.82 (15807-21058) 18568.24 (17624-19512) 
 3-4 Major ADGs 129 31008.39 (20625-41390) 34389.78 (30198-38581) 
 5+ Major ADGs 37 70643.21 (20288-120998) 58220.83 (46426-70015) 
Not Enrolled      
 <2 Chronic Conditions 267 12462.93 (9538-15387) 13854.77 (12643-15066) 
 0-2 Major ADGs 801 20584.87 (17509-23660) 20115.25 (19280-20950) 
 3-4 Major ADGs 306 35012.37 (28735-41289) 35899.65 (33142-38656) 
 5+ Major ADGs 68 45453.04 (32664-58241) 50595.07 (43701-57489) 
Medicaid Health Plan      
CM Enrolled      
 <2 Chronic Conditions 559 13304.71 (11352-15256) 14452.13 (13639-15264) 
 0-2 Major ADGs 828 20688.31 (18285-23090) 21111.68 (20413-21810) 
 3-4 Major ADGs 674 33614.48 (29927-37301) 31905.37 (30877-32932) 
 5+ Major ADGs 270 55127.34 (46356-63898) 48551.84 (45861-51242) 
Not Enrolled      
 <2 Chronic Conditions 367 15104.30 (12193-18015) 16397.10 (15336-17457) 
 0-2 Major ADGs 921 22844.16 (20399-25288) 20606.16 (19936-21275) 
 3-4 Major ADGs 1108 32327.76 (29808-34846) 31361.41 (30505-32217) 
 5+ Major ADGs 539 44167.91 (39650-48684) 44215.41 (42628-45801) 
Family Health Plan      
CM Enrolled      
 <2 Chronic Conditions 32 16694.27 (11001-22386) 22131.95 (18764-25499) 
 0-2 Major ADGs 244 23911.19 (18964-28858) 26701.01 (25469-27932) 
 3-4 Major ADGs 218 36013.98 (28062-43965) 35071.13 (33355-36786) 
 5+ Major ADGs 87 44620.77 (36311-52930) 55513.92 (49961-61066) 
Not Enrolled      
 <2 Chronic Conditions 42 21591.89 (4786-38397) 19827.27 (16623-23031) 
 0-2 Major ADGs 499 23318.14 (20388-26247) 22917.58 (22041-23794) 
 3-4 Major ADGs 444 32978.52 (28747-37209) 34482.54 (32908-36056) 
 5+ Major ADGs 137 42607.39 (32774-52440) 52735.41 (48287-57183) 
CI, Confidence Interval, CM, Care Management 
Adjusted: Sex, Age, Major ADG count, Care Management Level, Year1 Cost 
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Personal statement of research and research objectives 
I have a special interest in worldwide developments in Patient Classification and its application 
in Health planning, funding and resource allocation. I currently specialize in population health 
and primary care applications of predictive models, with research interests in Care Management 
in Primary Care and the measurement of Multiple Morbidity. Working with the team at Johns 
Hopkins University (USA) on the Adjusted Clinical Groups (ACG) System, I have worked on 
projects in a number of countries utilizing existing primary and secondary care data to create 
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population based analyses, and have developed expertise in mapping differing classification 
systems (morbidity and pharmacy) to build whole population databases. Current projects include 
the development of measures for care management participation in US care plans, development 
of predictive models to assist English family doctors in identifying patients in the population 
needing outreach services, and applying the ACG System to other primary care populations in 
Europe and Australia. 
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